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ABSTRACT OF DISSERTATION 
EXPLORING BIOPSYCHOSOCIAL (BPS) FACETS OF CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE (COPD) IN PATIENTS IN AN ACUTE INPATIENT 
PHYSICAL REHABILITATION FACILITY (IRF) 
From a BPS perspective, COPD and other chronic diseases may have a significant 
negative impact on those living with them and may be associated with higher rates of 
depression and anxiety and lower levels of health-related quality of life (HRQOL).  
Certain factors, such as spirituality, may influence the negative impact of chronic disease 
on the relationship between mood and functional independence and HRQOL.  Also, 
gender may influence the relationship between mood, spirituality, and HRQOL for men 
and women living with chronic diseases.  The current study included 136 patients 
undergoing physical rehabilitation at an IRF.  Anxiety, depression, spirituality, HRQOL, 
and functional independence were evaluated for all.  Mediation models were tested to 
determine the impact of spirituality on the relationships between mood and HRQOL and 
functional independence, and moderation models were tested to evaluate the impact of 
gender on the relationships between mood, spirituality, functional independence, and 
HRQOL.  The current study yielded some inconclusive results but did evidence that 
COPD patients in acute inpatient physical rehabilitation facilities (IRF) have higher 
levels of anxiety than patients without COPD and also revealed that men with COPD 
have better HRQOL than do women with COPD. Spirituality was found to partially 
mediate the relationship between depression and HRQOL in IRF patients with COPD, 
but gender did not appear to moderate the relationships between mood, spirituality, 
functional independence, or HRQOL in IRF patients.  As few studies on IRF patients 
with chronic diseases exist, continuing to evaluate patients in IRFs is important to 
enhance our BPS understanding of chronic disease. 
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Chapter One: Introduction and Literature Review 
More than 130 million Americans are living with a chronic medical illness 
(Sarafino & Smith, 2011).  Chronic disease, at the core, is a biomedical factor that also 
impacts individuals at social, spiritual, and psychological levels (chronic disease, chronic 
conditions, and chronic illness are terms that will be used interchangeably throughout the 
current document).  Chronic diseases have been conceptualized as conditions that last for 
indefinite periods of time and are characterized as health conditions least likely to have a 
cure (Martz & Livneh, 2007).  Such diseases may reveal themselves over time and 
present with symptoms that individuals may not always recognize until the illness has 
advanced.  In addition to hereditary factors, chronic illnesses may result from certain 
personal choices such as a sedentary lifestyle, poor diet, and substance use or abuse.   
 The Centers for Disease Control and Prevention (CDC, 2013) identify chronic 
diseases such as heart disease, cancer, and chronic lower respiratory diseases as being the 
leading causes of death and disability in the United States.  The CDC also recognizes that 
chronic diseases cause 7 out of 10 deaths in Americans annually.  Chronic conditions, 
according to the CDC and American Psychological Association, pose major limitations 
for those living with them; limitations may be physical, emotional, and social in nature 
(Dorlen, 2013).  Coping with a chronic disease may be emotionally overwhelming and 
frightening, potentially impacting quality of life (QOL).  Without adequate support and 
treatment, individuals with chronic illnesses may experience life-altering debilitation.  
 The chronic disease of focus in the current study is chronic obstructive pulmonary 
disease (COPD).  COPD is a progressive lung condition and is medically characterized 
by the production of excess sputum, restricted airflow to and from the lungs, and a 
chronic cough.  Many researchers and healthcare professionals recognize COPD as a 
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medical condition; COPD, however, also impacts individuals socially, psychologically, 
and spiritually (Burker, Evon, Sedway, & Egan, 2004; Wagena, Arrindell, Wouters, & 
Van Schayck, 2005).  The focus of the current study is on evaluating the relationship 
between COPD, mood, spirituality, health-related quality of life (HRQOL), and overall 
function in men and women in an acute physical rehabilitation program, which is 
essential to guide treatment and develop a comprehensive understanding of the disease 
process.  Knowledge gained from the current study may illustrate the different ways 
patients experience COPD in a particular type of healthcare setting.  Capturing the nature 
of the relationship between these biopsychosocial (BPS) facets (biological, 
psychological, sociological, and spiritual) while patients are undergoing inpatient 
physical rehabilitative treatment is important to determining whether focusing 
interventions during this point of disease recovery and treatment is beneficial and may 
further highlight the advantages of such treatment programs.     
Statement of the Problem  
 Current literature on COPD is vast and focuses on aspects of the disease such as 
the biological disease process, emotional experience, physical impact, and treatment.  
Most researchers recognize the fact that COPD greatly impacts various aspects of life 
such as mood, physical function, and social involvement (Aydin & Ulussahin, 2001; 
Brenes, 2003; Craig & Van Nutta, 1983; Dahlen & Jansen, 2002; Felker et al., 2001; Kim 
et al., 2000; Kunik et al., 2005; McSweeny, Grant, Heaton, Adams, & Timms, 1982; 
Prigatano, Wright, & Levin, 1984; Schrier, Dekker, Kaptein, & Dijkman, 1990; 
Yohannes, Baldwin, & Connolly, 2000) and have evaluated the patient experience of 
COPD in community, acute medical, or outpatient settings (Cully et al., 2006; Ferrer et 
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al., 1997; Kunik et al., 2005; Ng et al., 2007; Osman, Godden, Friend, Legge, & 
Douglas,1997; Stage, Middleboe, & Pisinger, 2005; Yohannes, Roomi, Baldwin, & 
Connolly, 1998; Yohannes et al., 2000).  Little research, however, has been conducted on 
the BPS facets of COPD in individuals in acute inpatient rehabilitation facilities (IRFs), 
and thus, we know very little about the BPS experiences of those with COPD who are 
engaged in acute inpatient physical rehabilitation programs.  The purpose of the current 
study is to further enhance our understanding of the relationship between BPS facets of 
COPD and inpatient pulmonary rehabilitation.  
Purpose of the Current Study 
 In the current study, I use the BPS model to examine the relationship between 
depression, anxiety, spirituality, health related quality of life (HRQOL), functional 
independence, and gender in patients in an IRF.  The BPS model will be more fully 
explained in the literature review section but is essentially a framework that emphasizes 
the importance of the interplay between biological, psychological, and sociological 
factors in the human experience of illness and disease process.  Research on the 
relationship between the previously mentioned variables and IRF patients may aid us in 
comprehending the emotional process that those living with chronic diseases face and 
may also add to the knowledge of the disease process itself.  By conceptualizing these 
relationships using the BPS model, we may be able to treat patients appropriately by 
providing emotional support and, ultimately, assist individuals living with chronic 
diseases, and specifically COPD, in developing adaptive tools and strategies to cope and 
improve HRQOL and functional independence throughout the disease process.  
Furthermore, we may foster health professionals’ understanding of the BPS complexities 
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of chronic diseases, thereby illustrating the importance of psychological intervention 
during the rehabilitation phase of treatment and attain the goal of improving HRQOL and 
functional independence for those living with chronic diseases and conditions.  As such, 
several research questions were evaluated in the current study to explore the connections 
between the aforementioned factors.  
Research Questions  
 The current study addressed the following research questions:  
1. How are individuals with COPD in acute IRFs different than IRF patients without 
COPD in terms of mood, functional independence, and spirituality? 
2. How does the HRQOL of women with COPD in acute IRFs differ in comparison to 
HRQOL of men with COPD in acute IRFs? 
3. What is the role of spirituality? Several specific questions are contained within the 
broader question, including: 
a. Does spirituality mediate the relationship between anxiety and HRQOL in IRF 
patients with COPD?  
b. Does spirituality mediate the relationship between depression and HRQOL in 
IRF patients with COPD?  
c. Does spirituality mediate the relationship between anxiety and functional 
independence in IRF patients?  And, 
d. Does spirituality mediate the relationship between depression and functional 
independence in IRF patients?  
4. What is the impact of gender? Several specific questions are contained within the 
broader question, including:  
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a. Does gender moderate the relationship between anxiety and functional 
independence in IRF patients with COPD?  
b. Does Gender moderate the relationship between depression and functional 
independence in IRF patients with COPD?  
c. Does gender moderate the relationship between spirituality and functional 
independence in IRF patients with COPD? 
d. Does gender moderate the relationship between anxiety and HRQOL in IRF 
patients with COPD?  
e. Does gender moderate the relationship between depression and HRQOL in IRF 
patients with COPD?  
f. Does gender moderate the relationship between spirituality and HRQOL in IRF 
patients with COPD?  
g. Does gender moderate the relationship between anxiety and functional 
independence in IRF patients?  
h. Does gender moderate the relationship between depression and functional 
independence in IRF patients?  And,  
i. Does gender moderate the relationship between spirituality and functional 
independence in IRF patients?  
A literature review of the aforementioned constructs under investigation in this study 
follows to provide the current state of research in the area of COPD and the context for 
the current study.  
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Literature Review  
In the following review, I explore the current state of the literature on QOL, 
HRQOL, depression, anxiety, gender, spirituality, and functional independence with 
respect to chronic disease in general and specifically COPD, as these factors have been 
deemed important when conceptualizing the BPS experience patients have of the disease 
process.  Researchers have focused on patients’ experiences in a variety of settings 
(Aydin & Ulussahin, 2001; Brenes, 2003; Cully et al., 2006; Garrido et al., 2006; Gift & 
Cahill, 1990; Gift, Plaut, & Jacox, 1986; Hill, Geist, Goldstein, & Lacasse, 2008; 
McSweeny et al., 1982; Prigatano et al., 1984; Schrier et al., 1990).  Research on patients 
in acute inpatient pulmonary rehabilitation programs, however, is limited.  As such, I also 
describe pulmonary rehabilitation and offer a rationale for why focusing BPS treatment at 
this stage of disease treatment may be beneficial.  
Chronic obstructive pulmonary disease.  Approximately 210 million people 
worldwide have COPD.  Though often unrecognized as a leading health concern by the 
general public when compared to ailments such as cancer and heart disease, COPD is 
currently recognized as the fourth leading cause of death in the United States (Pauwels, 
Buist, Calverley, Jenkins, & Hurd, 2001) and is predicted to become the third leading 
cause of death worldwide by the year 2030 (World Health Organization [WHO], 2013). 
COPD is a combination of two other chronic conditions, chronic bronchitis and 
emphysema.  Chronic inflammation of the bronchial tubes leads to a diagnosis of 
bronchitis.  The chronic inflammation causes a chronic cough along with excess mucous 
production.  With emphysema, lung tissue and alveoli are damaged, leaving air trapped in 
the lungs.  Dyspnea results from the chronic inflammation of the bronchial tubes as well 
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as the trapped air in the lungs.  Chronic symptoms of bronchitis and emphysema often 
lead to a diagnosis of COPD (Pauwels & Rabe, 2004). 
Though the etiology of COPD may vary, the disease is most often associated with 
a long-term history of cigarette smoking but may also be attributed to long-term exposure 
to environmental irritants such as industrial dust, chemical fumes, air pollution, or smoke.  
Most smokers develop respiratory problems as a result of COPD, with approximately 
50% of smokers developing respiratory symptoms of COPD.  According to researchers, 
45% of smokers between the ages of 46-77 years will develop COPD at some point in 
their lives (Marsh, Aldington, Shirtcliffe, Weatherall, & Beasley, 2006).   COPD may 
also result from hereditary factors or other types of chronic lung infections such as 
pneumonia.  Viral infections, as well as impairments in lung growth while in utero and 
childhood may put an individual at increased risk for developing COPD (Pauwels et al., 
2001).  Diagnosis of COPD is made by obtaining a detailed medical history and 
conducting lung function tests in addition to a physical examination that includes a chest 
X-ray.  Such physical symptoms lead to a variety of complications.  
 COPD often significantly impacts physical, social, and psychological functioning 
and may lead to diminished HRQOL.  Symptoms of COPD can range from mild to life-
threatening.  Those living with COPD often experience severe limitations in physical 
activity because of decreased lung capacity and related shortness of breath.  As a result, 
individuals with the disease experience decreased ability to perform simple activities of 
daily living such as vacuuming and laundry, as well as personal tasks such as grooming 
and eating.  Climbing even a minimal number of stairs may also become exhausting.  As 
the disease progresses, those living with COPD are prone to exacerbations in which 
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symptom severity increases significantly and often leads to frequent hospitalizations, 
thereby considerably amplifying the social and psychological burden of the disease 
(Pauwels & Rabe, 2004).  Following exacerbations and acute hospitalizations, individuals 
with COPD may be admitted to pulmonary rehabilitation programs for further treatment.  
Ideally, in a rehabilitation setting, an individual’s physical, psychological, and social 
aspects of health are addressed in an attempt to improve HRQOL.  One aspect of health 
typically addressed is mood, specifically depression related to the disease process.  
Depression and COPD.  Depression is a multi-faceted Axis I psychological 
mood disorder.  The American Psychiatric Association (2000) classifies depression as a 
mood disorder in which dysphoria and anhedonia are the overall prominent features.  
Included under the umbrella of mood disorders are depressive disorders: major 
depressive disorder, dysthymic disorder, and depressive disorder not otherwise specified.  
Each of these disorders centers on the identification of a depressed mood.  Diagnosis with 
one of the subtypes depends upon the duration of symptoms as well as the type and 
number of clinical features present.  Clinical symptoms of depressed mood may include 
appetite changes and sleep dysregulation, decreased energy or fatigue, low self-esteem, 
poor concentration or difficulty making decisions, and feelings of hopelessness.  In 
addition to these symptoms, a diagnosis of major depression is made when an individual 
experiences depressed mood most of the day, nearly every day, decreased pleasure in 
activities, weight changes, psychomotor agitation, and recurrent thoughts of death.  The 
main characteristic of a depression diagnosis is that the symptoms cause marked distress 
in the areas of social, emotional, physical, and occupational functioning.  Major 
depressive disorder is a leading cause of disability.  Researchers estimate that by 2020, 
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the number of years lost to death and disability from depression will be surpassed only by 
those due to heart disease (Kerr & Kerr, 2001).  Researchers have also discovered that 
depression may lead to impaired QOL (Coulehan, Schulberg, Block, Madonia, & 
Rodriguez, 1997; Cully et al., 2006; van Manen et al., 2002; Yohannes et al., 1998).  
A number of determinants of depression exist, including biological, cognitive, 
developmental and personality factors, comorbid disorders, and psychological stressors 
(Beck & Alford, 2009).  Biological factors, such as cerebral and immune system 
dysfunction, combine with cognitive factors (maladaptive schemata) to influence 
depressive related changes in mood (Beck & Alford, 2009).  Additionally, early 
developmental trauma and/or maltreatment and comorbid disorders including anxiety and 
substance abuse have been found to increase vulnerability to depression.  Individuals 
with personality disorders and increased exposure to psychological stressors have higher 
rates of depression when compared to the general public.  As noted, many factors 
contribute to depression (Beck & Alford, 2009).  Depression can be a severely 
debilitating disorder, psychologically, physically, and socially, especially for those with 
chronic diseases such as COPD (Hill et al., 2008; Ormel et al., 1998). 
Researchers across numerous studies have evaluated the relationship between 
COPD and depression in an attempt to enhance understanding of the psychological 
impact of the disease and have discovered that close to half of those living with COPD 
experience symptoms of depression (Aydin & Ulussahin, 2001; Brenes, 2003; Dahlen & 
Jansen, 2002; Felker et al., 2000; Kunik et al., 2005; Yohannes et al., 2000).  Depression 
also appears to impact physical and social functioning in patients with COPD (Ng et al., 
2007), which illustrates the fact that one’s experience of COPD is not solely medical in 
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nature.  Researchers have found that individuals with COPD who also endorse symptoms 
of depression (Kim et al., 2000) tend to experience physical symptom exacerbation 
(Cully et al., 2006), social isolation (Hill et al., 2008), persistent smoking, longer hospital 
lengths of stay (Ng et al., 2007), and earlier mortality (Stage et al., 2005) when compared 
to those without comorbid COPD and mood disturbance.  While research on the 
rehabilitation patient experience has historically been limited, other research has focused 
on those individuals with COPD who are in acute care (Ng et al., 2007), outpatient, or 
community settings (Yohannes et al., 1998).  Patients in these types of healthcare settings 
endorse moderate (Yohannes et al., 2000) to severe levels (Lacasse, Rousseau, & Maltais, 
2001) of depression.  Exploring the COPD patient’s experience of depression in the acute 
IRF setting is important to obtain a complete conceptualization of the disease process and 
determine whether treatment of depression in the acute inpatient rehabilitation setting is 
warranted.  In addition to symptoms of depression, COPD patients also appear to endorse 
symptoms of anxiety at higher rates than other patients and the general population.   
Anxiety and COPD.  The National Institutes of Mental Health (NIMH, 2012) 
recognizes anxiety disorders as a group of mental health disorders that include 
generalized anxiety, panic disorder, obsessive-compulsive disorder, post-traumatic stress 
disorder, social anxiety disorder, and specific phobias. The current manuscript will focus 
on DSM-IV-TR (2000) clinical symptoms of generalized anxiety which include 
restlessness or feeling keyed up or on edge, being easily fatigued, difficulty concentrating 
or mind going blank, irritability, muscle tension, and sleep disturbance as well as some 
symptoms of panic, as symptoms of panic may mimic symptoms of COPD and vice 
versa.  Symptoms of panic occur within a discrete period of time and may lead to intense 
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fear or discomfort.  Panic symptoms include palpitations and/or accelerated heart rate, 
sweating, trembling or shaking, sensations of shortness of breath or smothering, feeling 
of choking, chest pain or discomfort, nausea or abdominal distress, feeling dizzy, 
unsteady, lightheaded or faint, feelings of derealization or depersonalization, fear of 
losing control or going insane, sense of impending death, parasthesias, chills, or hot 
flashes.  As with depression, diagnosis of an Axis I anxiety disorder is also dependent 
upon the number of and length of time clinical symptoms are experienced and/or 
endorsed by an individual and whether the presence of symptoms cause marked distress 
in the areas of social, emotional, physical, and occupational functioning (American 
Psychiatric Association, 2000).   
Anxiety may serve to exacerbate disease symptoms in those with chronic 
diseases, increase the burden of disease, and may even be a risk factor for physical illness 
(Clarke & Currie, 2009).  Symptoms of anxiety may lead to increased and even excessive 
use of medication, increased lengths of hospital stay, more frequent hospitalizations, 
inadequate coping, and diminished engagement in rehabilitation programs (Agle & 
Baum, 1977).  As well, anxiety appears to have a significant impact on individuals living 
with COPD.   
Researchers have discovered that individuals with COPD are three times more 
likely to have generalized anxiety and symptoms of panic than the general public 
(Brenes, 2003; Hill et al., 2008).  COPD patients also experience anxiety at greater rates 
than individuals with other health conditions such as heart disease and cancer (Kvaal, 
Macijauskiene, Engedal, & Laake, 2001).  In addition to being disabled by a progressive 
lung disease, patients with COPD are further limited physically by symptoms of anxiety 
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(Aydin & Ulusahin, 2001) and endorse physiological symptoms of anxiety similar to 
somatic complaints of COPD including shortness of breath, fatigue, sweating, heart 
palpitations, and tachycardia.  Anxiety related to COPD often exacerbates problems with 
dyspnea (Gift & Cahill, 1990; Gift, Plaut, & Jacox, 1986), forced vital capacity (Borak, 
Chodosowska, Matuszewski, & Zielinski, 1998), and chest discomfort (Kellner, Samet, & 
Pathak, 1992).  Symptoms of anxiety also lead to increased hospitalizations in patients 
with COPD (Yohannes et al., 2000) and social isolation, which can severely limit QOL 
(Hill et al., 2008). 
QOL, HRQOL, and COPD.  QOL and HRQOL are concepts that have been 
reviewed extensively in the medical and social sciences literature.  While the concepts are 
related, important differences have been delineated.  To better understand these concepts, 
each will be broken down into separate areas within this literature review, beginning with 
a review of QOL. 
 The definition of QOL has been influenced by individual and societal perspectives, 
as well as a number of theoretical models, which can be applied to the concept (Felce & 
Perry, 1995).  Since World War II, the notion of QOL has been a major focus in the 
social sciences and medical literature.  Initially, the idea of QOL referred to material 
goods such as houses, cars, and expendable income.  American president Dwight D. 
Eisenhower recognized general QOL as incorporating the attainment of education, 
concern for the individual, economic stability and growth, welfare, and health.  As 
society became increasingly unstable, QOL began to take on a more individualistic focus, 
emphasizing personal care, freedom, and leisure and indicating the “good life” 
(Campbell, 1981; Farquhar, 1995).  During the post-war years, QOL was increasingly 
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defined in objective and measurable terms, emphasizing the value of consumer goods 
such as number of households with telephones or cars, as well as social statistics such as 
divorce rates (Farquhar, 1995). The subjective nature of QOL came into vogue again 
after the post-war years and as a result of the realization that the objective ideas of QOL 
and the subjective experience of life quality are not mutually exclusive.  Since then, 
exploration of QOL by researchers in the social sciences and medical literature has been 
extensive. 
Many definitions have been ascribed to the term QOL within the social sciences 
and medical literature.  Liu (1976) recognized the vast nature of the conceptualization of 
the term and purported that QOL should express the ideas that individuals find important.  
The expression has been used to reference general aspects of life as well as specific facets 
of health.  QOL has been conceived as being related to the conditions of life as well as 
the experiences of life on both individual and societal levels (McCall, 1975).  Some 
authors view QOL in similar but overall different ways, recognizing the importance of 
similar components but viewing QOL from objective and subjective perspectives.  The 
concept of QOL has been termed as multifaceted, encompassing individual aspects of 
behavior, cognition, and emotion related to career, family, and society, emphasizing the 
subjective and individual components of QOL (Dalkey & Roark, 1973; Tarter, Erb, Biller 
Switala, & Van Thiel, 1988; Young & Longman, 1983).  Shaw (1977) developed an 
objective formula to determine QOL: QL = NE x (H + S), where QL is QOL, NE is 
natural endowment, H is the factors provided to the individual by home and family, and S 
is the contributions of society.  Hornquist (1982) broadened the concept of QOL by 
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stressing the importance of fulfillment of satisfaction in the areas of physical, 
psychological, social, activity, structural, and material needs. 
In contrast to the subjective view, the more objective notion of QOL factors in 
socioeconomic status (Meeberg, 1993).  Hollandsworth (1988) supported the idea that 
QOL is a contribution of quantity of life rather than simply quality.  The more widely 
accepted definition of QOL is one that incorporates all aspects addressed.  “QOL is 
viewed as either subjective, objective, or both, and is conceptualized as either 
unidimensional or multidimensional” (Meeberg, 1993, p. 33).  Fundamentally, QOL is 
multidimensional; because the concept is subjective, the patient or individual perspective 
is given utmost importance.  The multidimensional nature of QOL is holistic and requires 
investigation in a number of areas of well-being including physical, emotional, and social 
functioning (Cella, 1994).  Overall, QOL appears to contain four attributes: general life 
satisfaction, adequate mental capacity with which to evaluate one’s life, acceptable state 
of health in terms of physical, mental, social, and emotional quality, and objectively 
adequate living conditions (Meeberg, 1993).  Comprehensively, and for the purpose of 
this study, QOL is conceived as the individual’s evaluation of “physical functioning, self-
maintenance, usual activities, social functioning, sexual functioning and intimacy, 
psychological well-being and distress, cognitive functioning, pain and discomfort, 
energy/fatigue, sleep, self-esteem, sense of mastery, perceived health, and life 
satisfaction” (Kane, 2003, p. 30).   
HRQOL is a construct related to QOL and is determined by the extent to which 
one’s health status influences the physical, emotional, and social factors of well-being.  
The concept of HRQOL is the value assigned to life when considering impairments, 
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disability, and social opportunities affected by disease and illness as well as disease 
management and treatment (Kane, 2003).  Guyatt, Feeny, and Patrick (1993) recognized 
that while many clinicians consider HRQOL to be related to illness and disease, other 
aspects of life such as income, freedom, and quality of one’s environment may be 
impacted when health is compromised.  Some believe that parceling out the effects of 
changing environment of social life, career, family, and aging on QOL and health may be 
impossible (Hunt, 1997).  The most agreed upon domains of HRQOL are “physical 
health and functioning, emotional health, cognitive functioning, role performance and 
work productivity, sexual functioning, and life satisfaction” (Kane, 2003, p. 30), which 
are also factors potentially impacted by COPD. 
Living with a chronic disease may be burdensome and impair HRQOL (Schlenk 
et al., 1997).  Researchers have discovered that those with COPD specifically experience 
a reduction in HRQOL (Garrido et al., 2006) secondary to impairments in physical 
performance, lack of adequate coping skills (Ketelaars et al., 1996), and medical 
complications that lead to physical symptoms such as fatigue and dyspnea.  These 
physical symptoms, disease exacerbations, frequent hospitalizations, as well as nebulizer 
treatment and oxygen therapy negatively affect HRQOL in COPD patients (Mahler & 
Mackowiak, 1995; Osman et al, 1997; Seemungal et al., 1998).  Some treatment 
modalities such as oxygen therapy, however, may actually serve to improve HRQOL of 
those living with COPD by alleviating the burden of dyspnea (Okubadejo, Paul, Jones, & 
Wedzicha, 1996) and decreasing social isolation.  Those in acute IRF settings are taught 
to effectively utilize and manage oxygen therapy to improve physical function.  
Therefore, one could reason that patients in IRF settings may have better HRQOL than 
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those in other healthcare settings; thus, one aspect of the current study is to better 
understand the relationship between COPD and HRQOL in patients in IRF settings.  The 
focus of treatment in IRF settings is functional independence.  
Functional independence and COPD.  In the current study, functional 
independence is conceptualized as an individual's ability to perform activities of daily 
living safely and autonomously and incorporates an individual's physical, cognitive, and 
psychological abilities with respect to medical illness (Uniform Data System for Medical 
Rehabilitation, 2012).  In the current study, the Functional Independence Measure (FIM) 
scale is used to measure functional independence.  Specifically, the scale addresses 
various domains of function including self-care, sphincters, mobility, communication, 
psychosocial, and cognition.  The self-care domain includes eating, grooming, 
bathing/showering, upper body dressing, lower body dressing, and toileting.  The 
sphincters domain includes bowel and bladder management.  The mobility domain 
includes transfers to the bed, chair, wheelchair, toilet, and tub/shower as well as 
locomotion (walking, wheelchair and stairs).  Communication includes auditory and 
visual expression and comprehension.  Psychosocial includes social interaction, and the 
cognition domain includes problem solving and memory.  Assessing functional 
independence in those with chronic disease is important to determine how the disease 
process impacts an individual's overall engagement in life and his or her ability to 
perform adequately.  Any impairment in function may serve to negatively impact 
HRQOL and negatively influence mood in those with chronic diseases (Uniform Data 
System for Medical Rehabilitation, 2012), especially in patients with COPD.  
17 
 
In addition to emotional impairment, those living with COPD also experience 
physical disability (Hill et al., 2008).  Shortness of breath has been reported by patients as 
being one of the most troubling and debilitating symptoms of COPD, severely limiting 
function and ability (Hajiro et al., 1998).  Those with severe dyspnea often have to use 
treatments such as oxygen therapy and nebulizers.  Individuals with COPD may also 
often need long-term oxygen therapy to maintain satisfactory oxygen levels even at rest.  
Debilitating physical and psychological symptoms of COPD negatively impact functional 
status of individuals with the disease (Aydin & Ulusahin, 2001; Felker et al., 2001; Ng et 
al., 2007).  In other words, COPD patients with psychological and physical impairments 
are also likely to have diminished levels of functional independence as physical debility 
may also lead to impairments in psychological well-being.    
Spirituality, religion, impact on health, and COPD.  Spirituality and religion 
are concepts that have become more frequently addressed in the medical literature in the 
past 30 years.  The area of spirituality has had a surge in interest, because many believe 
spirituality and religion strongly impact both physical and mental health, either positively 
or negatively (Cotton, Levine, Fitzpatric, Dold & Targ, 1999; Crawford, Handal, & 
Wiener, 1989; Daaleman & VandeCreek, 2000; Ellison, Gray, & Glass, 1989; Gurin, 
Veroff, & Fields, 1960; Fitchett, Rybarczyk, DeMarco, & Nicholas, 1999; Idler, 1987; 
Johnson & Mullins, 1989; Markides, 1983; Pollner, 1989; Poloma & Pendleton, 1989; 
Sloan, Bagiella, & Powell, 1999; Steinitz, 1980; Witter, Stock, Okun, & Haring, 1985).  
The meanings of the terms religion and spirituality are often debated.  Many use the 
terms interchangeably.  Some choose to use the word “spirituality” to describe all aspects 
of religion such as “beliefs, practices, and ethical teachings of specific religious bodies 
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and traditions” (Cohen, Wheeler, Scott, & The Anglican Working Group in Bioethics, 
2001, p. 31) including service and worship of a god or belief in a supernatural power 
(Lauver, 2000).  Others consider spirituality to be indicative of well-being, meaning, 
belief, hope (Sinclair, Pereira, & Raffin, 2006), life, significance, purpose, direction, and 
healing (Cohen et al., 2001) and regard religion as one of many types of spiritual 
expression.  For the current study, discussion of both terms, as well as discourse about the 
connection between spirituality, religion, and COPD, will follow. 
 Definition of spirituality.  Many definitions encountered during a review of the 
literature explain spirituality as being an internal (Johnstone, 2007) rather than an 
external system.  Spirituality transcends one’s physical existence (Kaye & Raghavan, 
2002; Miller & Thoresen, 2003; Musick, Traphagen, Koenig, & Larson, 2000) and 
emphasizes an existential component of belief systems and meaning and purpose in life.  
The term is considered an umbrella concept that encompasses faith, attitudes, personal 
views, and behaviors (Reed, 1987), regardless of one’s affiliation with organized religion 
(Muldoon & King, 1995; Tanyi, 2002).  Spirituality, within this framework, extends 
beyond reality (Molzahn, 2007), guides life and offers a meaning of death (Como, 2007), 
and focuses on creativity and spirit (Mitroff & Denton, 1999; Zinnbauer, Pargament, & 
Scott, 1999).  Many researchers consider spirituality to be inherent in all individuals 
(Miller, 1995) and view it as the essential domain of life (Connelly & Light, 2003).  
Spirituality is the very essence of our being and allows us to instill meaning into and 
become aware of who we are; “it shapes our life journey” (Dossey, Keegan, & Guzzetta, 
2000, p. 91).  Many people express being spiritual without being involved in specific 
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religious activities (Musgrave, Allen, & Allen, 2002).  Spirituality can also be considered 
private, whereas religion is public (Miller & Thoresen, 2003). 
 Definition of religion.   In contrast to spirituality, religion describes a more 
organized, society-based field of faith (Thoresen & Harris, 2002).  Someone who 
considers himself or herself to be religious may identify with organized groups such as 
Catholic, Christian, Buddhist, Hindu, Mormon, Jehovah’s Witness, and Jewish, 
Methodist, Baptist, and Protestant, for example.  Religion, in this sense, may be related to 
church involvement and other religious practices, as well as identification with a 
particular denomination of faith (Burker et al., 2004).  Religion usually characterizes a 
community of people who base belief on a certain deity (e.g., God or Allah) (Astrow, 
Puchalski, & Sulmasy, 2001).  Individuals often look to religion to provide them with 
guidelines for living (Spilka, Hood, Hunsberger, & Gorsuch, 2003).  “Religion is 
recognized as an external experience of formal expression with associated systems of 
worship, traditions, practices, doctrines, beliefs, moral codes, and accompanying dogmas 
that represent specific ideologies shared by a faith-based group,” (Johnstone, 2007, 
p.1154).  
 The current study focused on the relationship between both religion and 
spirituality or spiritual well-being on adult health and offers a review of these concepts in 
the social sciences and medical literature.  Evaluating the impact of spirituality on health, 
and specifically one's experience of COPD, is important when treating people living with 
chronic diseases; spirituality may serve to positively influence one's experience of 
COPD, thereby diminishing the overall negative impact of the disease. 
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 The relationship between spirituality and health has begun to receive increasing 
attention in the medical and social sciences literature.  Some have emphasized the 
influence spirituality has on a variety of health outcomes, both physical and mental.  
Many researchers have discovered a positive impact of religious affiliation on 
psychological health and well-being (Crawford, Handal, & Wiener, 1989; Ellison et al, 
1989; Gurin et al, 1960; Idler, 1987; Johnson & Mullins, 1989; Markides, 1983; Pollner, 
1989; Poloma & Pendleton, 1989; Steinitz, 1980; Witter et al, 1985).  Along the same 
lines, researchers have discovered a link between the more general, all-encompassing 
spirituality and depression, finding that those who identify themselves as spiritual display 
fewer symptoms of depression than those who do not consider themselves to be spiritual 
(Bussing, Matthiessen, & Ostermann, 2005; McClain, Rosenfield, & Breitbart, 2003; 
Nelson, Rosenfeld, Breitbart, & Galietta, 2002).   
 Shaw et al. (2007) conducted a study exploring the impact of religiosity in women 
with breast cancer.  The women in the group were part of a computer support group.  The 
researchers found that those women who used more words related to religion displayed 
fewer negative emotions, better perceived health self-efficacy, and improved functional 
well-being in comparison to those women who used fewer words related to religion.  
Additionally, religion has been found to impact mental illness and substance abuse 
(George, Larson, Koenig, & McCullough, 2000).  Many researchers have determined that 
religious affiliation and involvement may reduce the prevalence of such psychological 
diagnoses anxiety disorders (Koenig, Ford, George, Blazer & Meador, 1993; Koenig, 
George, Blazer, Pritchett, & Meador, 1993) and depression (Koenig, Hays, George, & 
Blazer, 1997).  Twelve-step programs such as Alcoholics Anonymous strongly 
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emphasize a religious component of recovery from addiction.  Other researchers have 
determined that religious affiliation, in fact, does alleviate symptoms of addictive 
disorders, such as substance abuse and dependence (Amoateng & Bahr, 1986; Amodeo, 
Kurtz, & Cutter, 1992; Gorsuch, 1993; Koenig, George, Meador, Blazer & Ford, 1994).  
On the other hand, others have not found a correlation between increased spirituality and 
increased psychological well-being (Cotton et al., 1999; Daaleman & VandeCreek, 2000; 
Sloan et al, 1999).   
Identification with spirituality may mediate the effects of several medical 
illnesses.  Tuck, Alleyne, and Thinganjana (2006) conducted a study in which they 
examined the link between spirituality and stress management in healthy adults.  The 
participants attended a spiritual growth group that focused on topics such as “the meaning 
and importance of spirituality and religion, expression of spirituality to others, creative 
expression of spirituality, infusion of knowledge and spirituality, multisensory experience 
and spiritual awareness, and forgiveness and spiritual well-being” (p. 247).  The 
researchers measured stress, spiritual perspectives, and spiritual well-being in addition to 
examining the meaning and importance of spirituality.  Results indicated that 
participation in a spiritual growth group was effective in reducing stress in terms of 
feelings of discomfort, changes in behavior such as body language, speech, and actions, 
and physical responses such as muscle tension, increased heart rate, and fatigue. 
To determine the impact of spirituality on health, Sears, Rodrigue, Green, 
Fauerbach, and Mills (1997) studied heart transplant recipients.  In the study, the 
researchers assessed the participants’ religious orientation, religious coping, and anxiety 
prior to surgery and then again after surgery.  The researchers evaluated HRQOL using 
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the Short Form-36 Health survey, which measures physical functioning, mental health, 
and general health.  Generally, the researchers found that those patients who had poorer 
religious coping strategies prior to heart transplant surgery experienced lower QOL, as 
well as poorer mental and general health than those with better religious coping 
strategies. 
Recognizing the importance of spirituality may also mediate the effects of certain 
acute, chronic, or terminal illnesses (Tuck et al., 2006).  Those with chronic illnesses, 
who participate in more religious activities, have been found to have fewer 
hospitalizations, shorter hospital lengths of stay (Koenig & Larson, 1998), and lower 
rates of mortality (Strawbridge et al., 1998) when compared to those with chronic 
illnesses who participate in fewer religious activities.  Mediator models in mental and 
physical health studies have suggested “a direct positive influence of religiousness on 
psychological well-being, optimism, perceived social support, and meaning in life, which 
in turn would positively affect psychiatric symptoms like depression or substance abuse 
behaviors” (Giaquinto, Sarno, Dall’Armi, & Spiridigliozzi, 2010, p. 329).  As well, 
researchers have discovered that the risk of death is lower in individuals who attend 
religious services weekly, and patients with medical disabilities who utilize spiritual 
coping appear to have lower levels of discomfort associated with the disease, higher 
levels of adjustment, and better quality of life when compared to patients who do not 
utilize spiritual coping (Giaquinto et al., 2010).  
Harvey and Silverman (2007) conducted a study on the mediating effects of 
prayer, a specific religious activity that leads one to feel a deeper spiritual connection 
with God, among elderly African American and White individuals and found that prayer 
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served to mediate the relationship between self-management and acceptance of chronic 
illness.  Specifically, the researchers discovered that by utilizing prayer regularly, elderly 
African American and White individuals with chronic disease were better able to accept, 
and thus manage the chronic illnesses.  Harvey (2006) also conducted a study on the 
mediating effects of prayer on the relationship between acceptance of chronic illness and 
chronic disease self-management among older African American women and found 
similar results.  The use of prayer as a coping mechanism appears to mediate the 
relationship between chronic disease self-management and acceptance of the disease, 
allowing individuals to accept and better manage the effects of the condition.   
Religiosity has also been found to have a mediating effect on pain (Kaczorowski, 
1989; Landis, 1996; O’Brien, 1982).  Attendance at religious functions has also been 
associated with lower blood pressure (Koenig et al., 1998), better immune system 
function (Koenig et al., 1997), and improved coping and self-efficacy (Koenig, George, 
& Titus, 2004; Larson, Swyers, & McCullough, 1998; Ventura et al., 2007).  
Additionally, religiosity may promote better recovery from illness, including faster 
recovery and reduced mortality after major surgeries (Harris, Dew, & Lee, 1995; Oxman, 
Freeman, & Manheimer, 1995).  In addition to recovery from surgery and decreased 
mortality, spirituality/religion may mediate the effects of chronic illness and disability 
(Lapane, Lasater, Allan, & Carleton, 1997).  Other researchers have discovered a 
paradoxical effect and assert that those with higher church affiliation actually have more 
cardiac disease risk factors when compared to church members with lower church 
affiliation (Lapane et al, 1997).  Based on the differential findings of these studies, the 
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need for continued work is apparent to further understand the influence of religion and/or 
spirituality on health outcomes for individuals with chronic illnesses such as COPD. 
Some researchers have focused on the spirituality and religiosity of individuals 
with COPD (Burker et al., 2004; Idler & Kasl, 1992).  Patients with COPD who are also 
involved in religious activities may suffer less from depression, anxiety, and physical 
disability when compared to those who do not spend time participating in religious 
activities.  As well, those COPD patients who consider disease to be a punishment from 
God also appear to have higher levels of depression and psychosocial disability (Burker 
et al., 2004).  Researchers have also discovered that active attendance in church services 
and participation within the church congregation are related to improved physical 
function and performance in daily activities of self-care among people with COPD (Idler 
& Kasl, 1992).    
In addition to outward displays of religiosity, private religion appears to be a 
protective factor against secondary disability in people living with COPD (Burker et al., 
2004).  Other researchers have found the opposite to be true for individuals without 
COPD and purport that in terms of health, religion does not provide protection from 
recovery from or adjustment to illness or disability (Fitchett et al, 1999).  The contrasting 
results of these studies on people with COPD and people without COPD and the fact that 
few studies on religion/spirituality in individuals with COPD exist indicate a need to 
further study religion/spirituality and disability in the IRF population.  
Gender, health, and COPD.  Like depression, anxiety, HRQOL, and 
spirituality/religion, gender is also characterized as a biological, psychological, and social 
factor in the current study.  The American Psychiatric Association (2000) recognizes that 
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women are at higher risk of developing depressive disorders during life than are men.  
COPD has historically been considered a disease that impacts mostly men, as men have 
higher rates of smoking and are more likely to have occupations that expose them to 
environmental irritants commonly associated with lung disease than are women 
(Chapman & Pye, 2001).  As a result, men are more likely to be diagnosed with COPD 
(Silverman et al., 2000) when compared to women. 
Studies on gender differences in health are numerous, and the risk factors for a 
variety of illnesses differ for men and women (Baum & Grunberg, 1991).  A few studies 
have been selected to illustrate gender differences in this area. 
In industrialized nations, the life expectancy for men is lower than for women.  
Women, however, have been found to report more health problems, utilize more 
medications, and report more disability than do men (Macintyre, 1993).  Women also 
self-evaluate their health as poorer and endorse more chronic symptoms than do men 
(Sweeting, 1994).  Men appear to report lower rates of illness in comparison to women 
(Miles, 1991).  As women age, they are more likely to experience decreased mobility and 
difficulty executing self-care tasks in comparison to men.  At the same time, however, 
women are less likely to assess their health as poor (Arber & Cooper, 1999), regardless of 
the finding that women report more health problems than do men.  The fact that gender 
differences exist in a variety of health conditions lends support for the study of gender 
differences in IRF patients, specifically those with COPD.  
Women with COPD display greater shortness of breath, more exacerbations, 
lower capacity for walking long distances, poorer QOL (de Torres et al., 2005; DiMarco 
et al., 2006), and more symptoms of depression in comparison to men with COPD 
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(DiMarco et al., 2006; Martinez et al., 2007), while men appear to be diagnosed with 
COPD more often than do women (Silverman et al., 2000).  As well, women tend to 
endorse higher perceived shortness of breath and suffer more from all aspects of COPD 
when compared to men.  As a result, women with COPD may have higher levels of 
depression and anxiety, poorer HRQOL, and endorse more physical disease symptoms 
such as perceived dyspnea when compared to men with COPD (Wagena et al., 2005).  As 
more women are being diagnosed with COPD (Silverman et al., 2000), the number of 
women dying from COPD is increasing (Chavannes et al., 2005).  As well, researchers 
have noted that gender does not moderate the relationship between COPD and depression 
(Zhang, Ho, Cheung, Fu, & Mak, 2011) or the relationship between COPD and anxiety 
(Holm, Bowler, Make, & Wamboldt, 2009) in the community and hospitals.   
Researchers in the medical field have noted that gender moderates relationships 
between a variety of constructs.  Research on coronary artery disease (CAD) revealed 
that gender moderates the relationship between anxiety and patient disposition; 
specifically, female patients who have anxiety and undergo a coronary artery bypass graft 
for CAD appear to have longer hospital lengths of stay than do male patients with anxiety 
who undergo the same surgical procedure (Dao, Voelkel, Presley, Doss, Huddleston, & 
Gopaldas, 2012).  Researchers have also explored the impact of gender on relationship 
between emotional response and disability in chronic pain patients and have found that in 
patients with high levels of depression, women appear to experience greater disability 
than do men.  Also, male patients with chronic pain and higher levels of depression tend 
to use more medications than do women with chronic pain and higher levels of 
depression.  Researchers have not found gender to moderate the relationship between 
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anxiety and disability (Keogh, McCracken, & Eccleston, 2006).  Regarding COPD, 
researchers have discovered that gender moderates the effects of exercise therapy on 
HRQOL among COPD patients; specifically, men experience greater HRQOL after 
extended exercise therapy in comparison to women (Foy, Rejeski, Berry, Zaccaro, & 
Woodard, 2001).  The experiences of both men and women with in IRFs should be 
evaluated while in rehabilitation settings to determine whether gender moderates the 
effects of certain BPS factors on the experience of chronic disease, specifically COPD.  
Information obtained may indicate that men and women participating in acute physical 
rehabilitation programs have different experiences than do patients in other healthcare 
settings; additionally, gender may moderate the relationships between certain variables in 
IRF patients.  Such information could indicate that IRF programs significantly influence, 
either negatively or positively, the BPS experience of men and women.  
Acute inpatient physical rehabilitation.  Because no cure exists for chronic 
illnesses, the medical community has emphasized the importance of disease management 
and improved HRQOL by preventing further physical decline (Foy et al, 2001).  As such, 
the benefits of acute inpatient physical rehabilitation programs are well documented.   
Patients with COPD may experience limited social interaction secondary to their 
physiological dependence upon oxygen therapy, decreased exercise tolerance, general 
physical decline, related dyspnea, and diminished psychological health (Ek & Ternestedt, 
2008; Habraken, Pols, Bindels, & Willems, 2008; Skillbeck et al., 1998).  Researchers 
have discovered that participating in recovery programs that offer treatment in various 
settings, including outpatients and primary care facilities, may improve QOL (Goldstein, 
Gort, Avendano, Stubbing & Guyatt, 1994; Wijkstra et al., 1995), HRQOL, functional 
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capacity (Lacasse et al., 1996; Stewart et al., 2001), and physiological health (Reis, 
Kaplan, Limberg, & Prewitt, 1995), reduce shortness of breath (Wijkstra et al., 1996), 
and improve mood (Penedo & Dahn, 2005).  A paucity of studies, however, has been 
conducted on COPD patients in acute inpatient physical rehabilitation settings (Bowen, 
Thrall, ZuWallack, & Votto, 1999).  Therefore, evaluating the relationship between the 
BPS facets of COPD of those in acute IRF settings may provide insight into the impact of 
inpatient physical rehabilitation, and thus, help identify the most appropriate point of 
intervention.  
A comprehensive pulmonary rehabilitation program emphasizes a 
multidisciplinary therapeutic approach.  In such a setting, individuals practice activities 
of daily living such as grooming, bathing, and eating as well as physical activities such as 
walking or utilizing assistive devices such as a walker or wheelchair.  Physical 
rehabilitation programs assist patients in improving strength and stamina, as well as in 
developing compensatory strategies for disease management.  The rationale behind 
participation in a physical rehabilitation program is to increase overall functional 
independence, thereby improving HRQOL by addressing physical, social, medical, and 
psychological aspects of the disease (Hill et al., 2008).  A holistic and BPS approach to 
acute inpatient pulmonary rehabilitation stresses emotional, physical, and social aspects 
of treatment.  A BPS intervention during this phase of recovery is pertinent to 
improvement in overall functional capacity.   
 The biopsychosocial model.  Several theoretical models of illness exist in 
healthcare.  The BPS model is widely accepted and was developed in response to what 
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many believed were shortcomings of the medical model.  Lazare (1973) recognized that 
the medical model is a model where: 
it is supposed that there eventually will be found a specific cause related to the 
functional anatomy of the brain.  The physician using the medical model concerns 
himself with etiology, pathogenesis, signs and symptoms, differential diagnosis, 
treatment and prognosis.  Knowing the syndrome or disease determines the 
treatment. (p. 346)  
Others consider the medical model to be rigid and reductionist (McLaren, 1998) and 
believe it fails to adequately address mental and behavioral health concerns (Johnson, 
2013).  Johnson (2013) recognizes apparent consequences of the dual paradigms as 
evidenced by the fact that healthcare providers are divided; physicians treat physical 
health ailments as psychologists treat cognitive, emotional, and behavioral health 
concerns.  As the current healthcare system moves more toward a patient-centered 
approach rather than one driven solely by physicians and medicine, focus on the BPS 
model becomes increasingly important.  Such a paradigm shift is especially salient for the 
field of psychology, as the BPS model embraces the treatment of mental health problems 
more so than does the medical model (Johnson, 2013).   
The BPS model, with foundations in general systems theory, takes into account 
the person, the environment, and the person’s disease to provide a holistic 
conceptualization of illness and direct a patient-centered clinical method (Butler, Evans, 
Greaves, & Simpson, 2004).  George Engel, an early proponent of the BPS model, 
recognized that the medical model falls short in contributing to understanding of disease 
and when treating the whole person by focusing solely on biological factors, failing to 
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emphasize the importance of concomitant social, cultural, and psychological aspects of 
disease, and specifically by ignoring the individual’s personal experience.  Thus, Engel 
proposed a more complete conceptualization of illness to include not only biological but 
also psychological, sociological, and cultural facets of the person’s experience and 
termed the model the BPS model (in Caplain, McCartney, & Sisti, 2004).  To attain an 
overall and complete understanding of one’s health, the impact of physical disease as 
well as cultural, social, and psychological factors must be assessed (Engel, 1980).  In so 
doing, healthcare providers “must also take into account the patient, the social context in 
which he lives, and the complementary system devised by society to deal with the 
disruptive effects of illness, that is, the physician’s role and the health care system” 
(Engel, 1980, p. 45).  Engel believed that psychological changes might have as much 
impact on the disease process as do biochemical alterations on a person’s experience of 
illness.  While a person presents with certain physiological symptoms, the subjective 
interpretation and experience of those symptoms is as important as the biochemical 
etiology.  The overarching goal of the BPS model is to affirm the patient’s experience 
(Butler et al., 2004).  According to the BPS model, treatment of any illness can be greatly 
impacted by psychosocial factors unique to the individual.  Some, however, have a 
contrasting view of the BPS model. 
Though much of contemporary psychology espouses the BPS model (Ghaemi, 
2009), others believe the model to be deficient when applied to individual treatment.  
Critics of the BPS model view the approach as simply one of eclectic freedom that allows 
clinicians to treat patients as they prefer without rationale for the prioritized direction or 
focus.  Critics also suggest that while the overarching goal of the BPS model is to treat 
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the individual rather than the disorder, clinicians often impose their own beliefs on the 
patients they treat (Ghaemi, 2009).  Such a course may lead treatment providers to 
attempt to piece together unrelated biological, psychological, and sociological data with 
little cohesion (McLaren, 1998).  Others have called into question the predictive power of 
the model and have questioned the rationale to attempt to discover a biological outcome 
by way of a psychological predictor or vice versa (McLaren, 1998; Weiner, 2008).  
Despite the shortcomings of the BPS model, one cannot ignore the positive contributions 
of the BPS model to the field of healthcare or the idea that utilization of the model in 
healthcare settings has led to advances in disease treatment when focusing on the 
individual experience of illness (Weiner, 2008).  
Researchers have found  “an ever-growing scientific literature demonstrating the 
heuristic value of this model in developing more effective assessment and treatment 
methods for [certain] disorders, as well as guiding greater cutting-edge research on their 
etiologies and potential prevention techniques” (Gatchel & Turk, 2008, p. 2831).  The 
model has been found sufficient when applied to a variety of conditions including chronic 
pain (Waddell, 1987), youth obesity (Goetz & Caron, 1999), HIV/AIDS (Orsulic-Jeras, 
Shepherd, & Britton, 2003), and substance abuse (Fisher & Harrison, 1999) to name only 
a few.  A more complete understanding of COPD through a BPS framework may allow 
for more appropriate, effective, and successful treatment. 
 BPS model and COPD.  Because COPD is typically viewed exclusively as a 
medical condition, treatment of the condition has historically been guided by the medical 
model (Lox & Freehill, 1999).  Since the 1970’s, however, the medical model has been 
deemed insufficient when treating those with COPD as healthcare providers came to 
32 
 
more fully recognize the physical, social, and psychological impact of the disease (Lox & 
Freehill, 1999).  In combination with biological and physical factors, COPD also leads to 
decreased social and psychological functioning and may lead to diminished overall 
HRQOL.  As such, the BPS model is superior to the medical model when treating mood 
conditions in individuals with COPD; therefore, the current study uses the BPS model to 
facilitate understanding of the relationship between BPS facets and COPD treatment and 
outcomes in an IRF setting.  As mentioned, the BPS factors evaluated in the current study 
are: depression, anxiety, HRQOL, functional independence, spirituality, and gender.  
Following is a review of those factors within the BPS framework.  
 BPS model and depression.  As previously stated, the BPS model takes into 
account both the person and the person’s disease to provide a holistic conceptualization 
of illness in terms of biological, psychological, and social factors.  The BPS model of 
depression recognizes the biochemical, social, psychological, and subjective factors that 
coalesce to provide a holistic view of the mood disorder (Engel, 1980).  Treatment of 
depression depends not only on the expertise of the healthcare provider but also on the 
individual and his or her subjective experience. 
Lewinsohn, Hoberman, and Hautzinger (1985) suggest that unhappiness may 
have foundations in a number of areas related to the BPS model.  In addition to the belief 
that depression results from biochemical alterations in neurotransmitters located in the 
brain, Lewinsohn and colleagues (1985) proposed that depression may arise from one’s 
personal appraisal of social interactions with the environment as well as a lack of 
response-contingent reinforcement.  The lack of response-contingent reinforcement leads 
individuals to reward their own dysfunctional behaviors resulting from lack of self-
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control, insufficient self-monitoring, and distorted evaluations.  Such patterns reinforce 
and sustain feelings of unhappiness and negative cognitions.  Those have regular 
interpersonal interactions with others and evaluate such interpersonal relationships as 
satisfactory and fulfilling may be happier than those who have irregular and 
unsatisfactory or unfulfilling interpersonal interactions. In short, dysfunctional cognitions 
lead individuals to overreact emotionally to situations encountered in the environment.  
Certain emotional reactions to chronic disease are normal.  Therefore, understanding 
extreme and maladaptive emotional responses to chronic diseases such as COPD in terms 
of the BPS model may allow healthcare professionals to provide their patients with more 
holistic treatment; specifically, identifying and understanding the mediators between 
depression and COPD within a BPS framework may prove useful when treating those 
coping with both conditions. 
 Individuals with chronic diseases such as COPD are impacted not only physically 
but also culturally, socially, and psychologically.  Increasing physical and functional 
impairments lead individuals living with such debilitating diseases into a different 
culture, one of disability.  The recognition of being disabled often leads to depression, 
anxiety, and an overall decrease in HRQOL.  Such extreme changes in one’s way of life 
may serve to perpetuate and reinforce social isolation, thereby keeping those with chronic 
illness in a state of unhappiness.  Applying the BPS model may prove useful when 
evaluating the impact of COPD on other aspects of psychological health as well, 
specifically anxiety. 
 BPS model and anxiety.  Barlow (2002) suggested that anxiety has BPS 
underpinnings. The biological basis of anxiety begins with a discussion of the nervous 
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system.  The nervous system informs the body of threat and then takes subsequent 
appropriate actions based on the level of threat.  While fear is the body's reaction to 
danger, anxiety, or the mind's response to the stimulus, is the anticipation of such danger.  
Once the mind perceives a stimulus as a threat, the fear response is activated, and the 
body reacts accordingly.  The subsequent biological reactions involve several nervous 
system components, such as the limbic system, the autonomic nervous system, the 
cardiovascular and respiratory systems and the excretory, digestive, and endocrine 
systems.  The process does not begin, however, until the individual encounters a trigger 
and assigns value of threat to that trigger; the value assigned to the stimulus is an 
individual process and arises from the individual's personal interpretation, or cognitive 
appraisal of the stimulus.  Upon encountering danger, an individual must then determine 
whether he or she has the ability to control the related stress; the determination of control 
is also based on the individual's interpretation or perception.  If an individual believes he 
or she can manage the stress, anxiety is diffused; however, if an individual does not 
believe he or she can manage the stress of an anxiety-inducing situation, anxiety may 
escalate (Barlow, 2002). 
 Many psychologists, including Barlow (2002) believe that the development of our 
perception of control is influenced by social experiences from childhood and social 
learning theory.  Barlow purports that we learn ways to think and behave by observing 
those around us.  Our perception of control and learned thoughts and behaviors are then 
strengthened by experiences we continue to have throughout our lives; such experiences 
may include exposure to and interaction within family dynamics, significant life 
stressors, and exposure to traumatic events.  
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 The body's physiological response to fear-inducing stimuli follows the 
interpretation of stimuli; such interpretation arises from the thoughts, beliefs, and 
perceptions (our psychological makeup) we develop while interacting with the social 
environment.  As well, depending upon personality characteristics, psychological well-
being, and biological makeup, certain individuals have more of a genetic vulnerability to 
experience anxiety while interacting within their environments.  Once the biological and 
psychological vulnerabilities are solidified, individuals then learn socially to focus 
anxiety on certain objects or situations, thereby strengthening the triggers. The social 
environments also include role models that significantly influence preexisting 
vulnerabilities and thus, influence individual interpretations of triggers (Jacofsky, Santos, 
Khemlani-Patel, & Neziroglu, 2010). 
 Recognizing the connection between COPD and anxiety from a BPS perspective 
is important for healthcare professionals and may enhance and strengthen understanding 
of COPD, as well as the patient's experience of the disease.  Applying a BPS framework 
to anxiety is critical, especially when treating men and women with COPD, as many of 
the symptoms of both COPD and anxiety are similar and may severely limit and 
negatively impact overall HRQOL. 
 BPS model and HRQOL.  The notion that medical conditions impact a person's 
existence and overall QOL is clear (Levenstein, 2004).  HRQOL and the tenets of the 
BPS model are related.  As mentioned, HRQOL takes into account physical and 
emotional health as well as one's social role.  The core concepts of the BPS model 
incorporate the same ideas (Levenstein, 2004):   
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It makes sense nonetheless to hope that improvement in mood and in coping 
strategies could have a moderating influence on patients' level of concern by 
decreasing their engagement with their disease, and could bring overall 
improvement in their health-related quality of life. (p. 2) 
Essentially, the hope is that enhancements in mood, social interaction, and disease self-
management will also improve HRQOL.  For those with chronic conditions, 
psychological vulnerabilities, and impaired coping, the disease process may be intensified 
and HRQOL lowered (Levenstein, 2004).  Psychological interventions may serve to 
enhance and preserve HRQOL by minimizing the negative physical, social, and 
psychological impact of diseases (Ryan & Carr, 2010) such as COPD.  In addition to the 
aforementioned factors, many who espouse the BPS model also recognize the influence 
of the chronic disease process and experience on functional independence.  
 BPS model and functional independence.  Conceptualizing functional status 
from a BPS perspective makes sense when considering chronic illness.  Chronic illnesses 
likely impact an individual's whole experience of existence, which includes biological, 
psychological, and social experiences.  One could conjecture that those who are more 
functionally independent also have better HRQOL when compared to those with less 
functional independence.  As well, WHO has adopted the BPS model and incorporated 
the model into the International Classification of Functioning, Disability and Health 
(ICF).  WHO's ICF model is a widely accepted framework for disability and 
rehabilitation and recognizes that daily functioning is a dynamic interaction "between the 
individual's health condition and related factors that include both personal/psychological 
and social/occupation factors.  Understanding and preventing incapacity requires a 
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framework that addresses all the physical, psychological, and social factors involved in 
human illness and disability" (Heads of Workers' Compensation Authorities, Heads of 
Compulsory Third Party Biopsychosocial Injury Management, p. 2, 2011).  In a study 
comparing those with lung disease, Gore and colleagues (2000) examined the differences 
between those with COPD and those with lung cancer and discovered that the patients 
with COPD fared worse in terms of overall physical ability and capacity to adequately 
complete activities of daily living.  Such findings are important when considering the 
overall experience of the COPD patient and illustrate a need to conduct more research on 
acute IRF patients with COPD.  Some researchers espouse the idea that the overall 
experience of a person is influenced by spirituality; thus a discussion of spirituality 
within the BPS framework follows.  
 BPS model and spirituality.  Many scholars now propose expanding the BPS 
model to include spirituality and suggest changing the name to the biopsychosocial-
spiritual model (Collins, 2007; Culliford, 2011; Sulmasy, 2002).  Many recognize the 
importance and impact of spirituality on psychological, social, and physical well-being 
and emphasize including spirituality to fully understand the person (Sulmasy, 2002) and 
one's experience of chronic illness: 
 Everyone, according to this model, has a spiritual history.  For many persons, this 
spiritual history unfolds within the context of an explicit religious tradition.  But, 
regardless of how it has unfolded, this spiritual history helps shape who each patient is as 
a whole person, and when life-threatening illness strikes, it strikes each person in his or 
her totality.  This  
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totality includes not simply the biological, psychological, and social aspects of the 
person, but also the spiritual aspects of the whole person as well.  This 
biopsychosocial-spiritual model is not a "dualism" in which a "soul" accidentally 
inhabits a body.  Rather, in this model, the biological, the psychological, the 
social, and the spiritual are only distinct dimensions of the person, and no one 
aspect can be disaggregated from the whole.  Each aspect can be affected 
differently by a person's history and illness, and each aspect can interact and 
affect other aspects of the person. (p. 27) 
Essentially, Sulmasy (2002) purports that spirituality plays a key role in the development 
of a person as a being, influences that person’s entire life, and one’s gestalt is comprised 
of biological, psychological, spiritual, and social factors.  People coping with chronic 
illnesses are likely impacted in all those dimensions.  Sulmasy’s view of spirituality as an 
integral component of a person’s development is important to consider when exploring a 
person’s experience of chronic disease.   
 BPS model and gender.  Gender identity develops as a direct result of a complex 
interaction between biological, social, and psychological factors.  For the purposes of the 
current manuscript and study, a basic view of gender identity will be explored, as the 
literature on this topic is extensive.  Sex, as referred to the physical structure of one's 
body, is primarily biologically determined.  The American Medical Association Manual 
of Style (Iverson et al., 1998) connotes that sex is the biological characteristics of males 
and females (and may have a major impact on the ways individuals express themselves 
and interact within their environments.  Gender identity, or one's experience of sex or 
concept of what being male or female means, is greatly influenced by the interaction 
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between biology, psychology and environment (WHO, n.d.).  Even as we age, our 
experience of the meaning behind being male or female evolves as a result of our social 
and psychological experiences (Committee on Understanding the Biology of Sex and 
Gender Differences, Board on Health Sciences Policy, 2001).   
 Such experiences vary between men and women, and the differences have long 
been a focus in social sciences and medical literature.  The 2001 US Institute of Medicine 
report indicated the existence of gender differences with respect to the experience of 
major diseases and response to therapy.  Healthcare professionals have identified gender 
differences in conditions such as autoimmune, metabolic, and cardiovascular diseases, 
certain types of cancer and movement disorders, as well as psychological disorders.  
Evaluating gender differences in COPD, specifically in an acute IRF, is important for 
healthcare professionals to understand the differences in ways men and women 
experience COPD, as well as co-morbid conditions and response to treatment.  
Examining BPS differences between men and women participating in an inpatient 
pulmonary rehabilitation program may aid health professionals in understanding the 
patient’s experience of COPD. 
 BPS model and pulmonary rehabilitation.  Pulmonary rehabilitation programs 
are typically multidisciplinary in nature.  The overall goal of such programs is to provide 
comprehensive treatment of physical and psychosocial aspects of pulmonary disease 
(Fischer et al., 2009).  Successful completion of a pulmonary rehabilitation program may 
serve to enhance HRQOL of men and women living with COPD by promoting sufficient 
disease self-management (Bourbeau, 2009).  Conducting further research on individuals 
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participating in an acute inpatient pulmonary rehabilitation program may bolster our 
understanding of the patient’s BPS experience of COPD.   
 The BPS model is founded in general systems theory.  The model was developed 
to compensate for shortcomings of the medical model and focuses on a holistic 
conceptualization of a person’s life experiences.  A person’s overall experience is 
comprised of a variety of factors, which include biological, psychological, sociological, 
and spiritual dimensions (Barlow, 2002; Jacofsky et al., 2010; Sulmasy, 2002; WHO, 
n.d.), which blend together to create one’s HRQOL (Lewinsohn et al., 1985).  The 
development of a chronic illness such as COPD may serve to negatively influence a 
person’s HRQOL (Levenstein, 2004; Lox & Freehill, 1999).  Based on the BPS model, 
participation in a comprehensive and multidisciplinary pulmonary rehabilitation program 
may be expected to alleviate the negative impact of COPD (Bourbeau, 2009; Fischer et 
al., 2009). 
The Current Study 
COPD is a chronic lung disease that is predicted to become the third leading cause 
of death worldwide by 2030.  Researchers have discovered that men and women living 
with COPD often experience impairments in mood, functional status, biophysical and 
social function, and HRQOL.  Endorsement of spiritual beliefs as well as participation in 
pulmonary rehabilitation programs that promote holistic treatment based on the BPS 
model may serve as protective factors against the deleterious effects of the disease.  
Though many researchers recognize the tremendous negative impact of COPD, few have 
examined the BPS facets of the disease in individuals in acute IRF settings.   
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 In the current study, I use the BPS model to examine the relationships between 
depression, anxiety, spirituality, HRQOL, functional independence, and gender among 
IRF patients as well as COPD patients in an IRF.  Results of the study will foster a deeper 
understanding of the BPS complexities of chronic diseases such as COPD and 
supplement the current literature.  Enhancing our knowledge of chronic diseases such as 
COPD may ultimately guide us in improving treatment and ultimately improving 
HRQOL and overall functional independence for those coping with such debilitating 
diseases.  As such, several research questions were employed in the current study to 
explore the connections between the aforementioned factors and are listed as follows:  
1. How are individuals with COPD in acute IRFs different than IRF patients without 
COPD in terms of mood, functional independence, and spirituality? 
2. How does the HRQOL of women with COPD in acute IRFs differ in comparison to 
HRQOL of men with COPD in acute IRFs? 
3. What is the role of spirituality? Several specific questions are contained within the 
broader question, including:  
a. Does spirituality mediate the relationship between anxiety and HRQOL in IRF 
patients with COPD?  
b. Does spirituality mediate the relationship between depression and HRQOL in 
IRF patients with COPD?  
c. Does spirituality mediate the relationship between anxiety and functional 
independence in IRF patients? And  
d. Does spirituality mediate the relationship between depression and functional 
independence in IRF patients?  
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4. What is the impact of gender? Several specific questions are contained within the 
broader question, including:  
a. Does gender moderate the relationship between anxiety and functional 
independence in IRF patients with COPD?  
b. Does Gender moderate the relationship between depression and functional 
independence in IRF patients with COPD?  
c. Does gender moderate the relationship between spirituality and functional 
independence in IRF patients with COPD?  
d. Does gender moderate the relationship between anxiety and HRQOL in IRF 
patients with COPD?  
e. Does gender moderate the relationship between depression and HRQOL in IRF 
patients with COPD?  
f. Does gender moderate the relationship between spirituality and HRQOL in IRF 
patients with COPD?  
g. Does gender moderate the relationship between anxiety and functional 
independence in IRF patients?  
h. Does gender moderate the relationship between depression and functional 
independence in IRF patients? And  
i. Does gender moderate the relationship between spirituality and functional 
independence in IRF patients?  
The research hypotheses employed to address the research questions are as follows: 
Hypothesis 1.  IRF patients with COPD differ in terms of levels of depression when 
compared to IRF patients without COPD (H0: µCOPD = µnonCOPD; H1: µCOPD ≠ µnonCOPD). 
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Hypothesis 2.  IRF patients with COPD differ in terms of levels of anxiety when 
compared to IRF patients without COPD (H0: µCOPD = µnonCOPD; H1: µCOPD ≠ µnonCOPD). 
Hypothesis 3.  IRF patients with COPD differ in terms of level of functional 
independence when compared to IRF patients without COPD (H0: µCOPD = µnonCOPD; H1: 
µCOPD ≠ µnonCOPD). 
Hypothesis 4.  IRF patients with COPD differ in terms of level of spirituality when 
compared to IRF patients without COPD (H0: µCOPD = µnonCOPD; H1: µCOPD ≠ µnonCOPD). 
Hypothesis 5.  Women with COPD differ in terms of HRQOL in comparison to men 
with COPD (H0: µwomenCOPD = µmenCOPD; H1: µwomenCOPD ≠ µmenCOPD). 
Hypothesis 6.  Spirituality mediates the relationship between anxiety and HRQOL in IRF 
patients with COPD.  
Hypothesis 7.  Spirituality mediates the relationship between depression and HRQOL in 
IRF patients with COPD.  
Hypothesis 8.  Spirituality mediates the relationship between anxiety and functional 
independence in IRF patients. 
Hypothesis 9.  Spirituality mediates the relationship between depression and functional 
independence in IRF patients.  
Hypothesis 10.  Gender moderates the relationship between anxiety and HRQOL in IRF 
patients with COPD. 
Hypothesis 11.  Gender moderates the relationship between depression and HRQOL in 
IRF patients with COPD.  
Hypothesis 12.  Gender moderates the relationship between spirituality and HRQOL in 
IRF patients with COPD.  
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Hypothesis 13.  Gender moderates the relationship between anxiety and functional 
independence in IRF patients with COPD. 
Hypothesis 14.  Gender moderates the relationship between depression and functional 
independence in IRF patients with COPD.  
Hypothesis 15. Gender moderates the relationship between spirituality and functional 
independence in IRF patients with COPD.  
Hypothesis 16. Gender moderates the relationship between anxiety and functional 
independence in IRF patients.  
Hypothesis 17. Gender moderates the relationship between depression and functional 
independence in IRF patients.  
Hypothesis 18. Gender moderates the relationship between spirituality and functional 
independence in IRF patients.  
Operational definitions.  The variables under examination in the current dissertation are 
(a) diagnosis of COPD, (b) level of depression, (c) level of anxiety, (d) level of functional 
independence, (e) level of spirituality, (f) level of HRQOL in those with COPD, and (g) 
gender.  Operational definitions for the constructs are  
• diagnosis of COPD as listed in the patient’s medical chart; a score of 0 indicates no 
diagnosis of COPD, while a score of 1 indicates a diagnosis of COPD. 
• level of depression defined as score of 0-30 on the GDS, with lower scores indicating 
lower levels of depression;  
• level of anxiety defined by score of 0-63 on the BAI, with lower scores indicating 
lower levels of anxiety;  
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• level of spirituality defined by a score of 0-92 on the FACIT-Sp, with lower scores 
indicating lower levels of spirituality; 
• level of functional independence defined as a score of 0-126 on FIM, with lower scores 
indicating lower levels of independence;  
• HRQOL defined by a score of 0-140 on the CRQ, with higher scores indicating higher 
levels of HRQOL; and  
• gender as indicated by one’s identification as either male or female; male was coded as 
0, and female was coded as 1.  
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Chapter Two: Method 
In the following section, I describe the sample, study procedure, instruments, 
research and statistical hypotheses, study design, and materials used in the current study.  
Sample 
Sample data were collected from men and women who were admitted to the 
pulmonary unit of an acute IRF in Central Kentucky.  Prior diagnosis of depression 
and/or anxiety was not a requirement for participation in the study.  All individuals who 
were admitted to the pulmonary unit at the IRF were included in the sample to allow for a 
comparison between those with COPD and those with no diagnosis of COPD.  The entire 
sample was comprised of 136 patients.  Fifty-five patients had COPD (40.4%); the 
remaining 81 patients (59.6%) in the sample had a variety of other diagnoses such as 
orthopedic injuries related to falls, cardiac diseases, were post-surgery patients (knee/hip 
replacements, spinal surgeries, limb amputations), and had no diagnosis of COPD or 
other lung disease.  Admission to the pulmonary unit for those without lung disease was 
sometimes necessary in cases of decreased bed availability on other facility units.  
In the total sample, 93.4% of respondents identified themselves as Caucasian; the 
remaining patients (6.6%) identified themselves as African American.  In the total 
sample, 92 patients were female (67.6%), and the mean age was 69.6 years.  Of those 
with COPD (n = 55), 96.4% were Caucasian, and 3.6% were African American.  In the 
COPD group, 74.5% were female, and 25.5% were male. The average age of those in the 
COPD sample was 68.93 years; the youngest patient with COPD was 46 years old.  In the 
non-COPD group (n = 81), 63% were female; 37% were male.  Also in the non-COPD 
group, 91.4% were Caucasian, and 8.6% were African American.  The average age of the 
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non-COPD group was 70.1 years.  Sample characteristics for the COPD group are listed 
in Table 1, sample characteristics for the non-COPD group are listed in Table 2, and 
sample characteristics for the IRF group (COPD and non-COPD patients combined), are 
listed in Table 3.  
Table 1 
Sample Characteristics of the COPD Group (n=55) 
Characteristic  n % 
Age category (years)    
     <40  0 0.0 
     40-49  3 7.3 
     50-59  8 12.7 
     60-69  17 30.9 
     70-79  20 36.4 
     80-89  7 12.7 
     >89  0 0.0 
Gender    
     Male  14 25.5 
     Female  41 74.5 
Race/ethnic group    
     Caucasian  53 96.4 
     African American  2 3.6 
 
Table 2 
Sample Characteristics of the non-COPD Group (n=81) 
Characteristic  n % 
Age category (years)    
     <40  4 4.9 
     40-49  3 3.7 
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Table 2 (continued) 
     50-59  9 13.6 
     60-69  18 21.0 
     70-79  23 28.4 
     80-89  18 22.2 
     >89  5 6.2 
Gender    
     Male  30 37.0 
     Female  51 63.0 
Race/ethnic group    
     Caucasian  74 91.4 
     African American  7 8.6 
 
Table 3 
Sample Characteristics of the IRF Group (n = 136) 
 
Characteristic  n % 
Age category (years)    
     <40  4 2.9 
     40-49  6 4.4 
     50-59  18 13.2 
     60-69  35 25.7 
     70-79  43 31.7 
     80-89  25 18.4 
     >89  5 3.7 
Gender    
     Male  44 32.4 
     Female  92 67.6 
Race/ethnic group    
     Caucasian  127 93.4 
     African American  9 6.6 
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Procedure 
The current study was approved on June 12, 2012 by the Institutional Review 
Board at the University of Kentucky and the Cardinal Hill Rehabilitation Hospital 
Research Committee, and the following procedures were employed.  Original data 
collected between the years of 2008 and 2009 were used in the study; thus, the 
information in the current study is part of an archival dataset.  Informed consent for 
participation was obtained prior to the collection of data as part of the hospital admission 
process and prior to the primary investigator's receipt of the dataset (see Appendix B).  
Data were in a Statistical Package for the Social Sciences (SPSS) database upon the 
primary investigator’s receipt.  Each participant's information was de-identified and 
entered into SPSS prior to the primary investigator's receipt of the dataset.   
 At the time of the original data collection, all new patients with all diagnoses who 
were admitted to the inpatient pulmonary rehabilitation program at the hospital were 
solicited for participation.  Participants were in naturally occurring groups and either had 
a diagnosis of COPD or no diagnosis of COPD; thus, random assignment of participants 
to groups was not appropriate.  All participants completed the BAI, GDS, and FACIT-Sp 
to assess for anxiety, depression, and spirituality, respectively.  All patients’ levels of 
functional independence were evaluated using the FIM tool.  Patients with COPD also 
completed the CRQ to assess HRQOL.  Individuals identified themselves as either male 
or female.  All patients were administered a variety of measures for the current study. 
Instrumentation 
Five measures were utilized in the study to measure BPS facets under 
investigation.  These measures included the Beck Anxiety Inventory (BAI), Chronic 
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Respiratory Questionnaire (CRQ; assessed in the COPD group only), Functional 
Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp), 
Functional Independence Measure (FIM), and Geriatric Depression Scale (GDS).  These 
five measures are described in more detail in the following sections.  The BAI, CRQ, 
FACIT-Sp, and FIM are copyrighted measures, and thus, are not reproduced in this 
manuscript. The GDS is in the public domain and is included in the appendices.  
Anxiety.  The BAI is a 21-item multiple-choice self-report inventory that is used 
to assess anxiety severity.  The measure has been utilized in a number of studies and has 
strong psychometric properties.  In their study used to evaluate the psychometric 
properties of the BAI, Beck, Epstein, Brown, and Steer (1988) sampled psychiatric 
outpatients (n = 1086) from a center for cognitive therapy in Philadelphia, Pennsylvania.  
The final subsample of the sample used (n = 160) was comprised of individuals with 
“major depressive disorder (n = 40), dysthymic disorder and atypical depression (n = 11), 
panic disorder (n = 45), generalized anxiety disorder (n = 18), agoraphobia with panic 
attacks (n = 18), social and simple phobia (n = 12), and miscellaneous nonanxiety,  
nondepression disorders such as academic problems and adjustment disorders (n = 16)” 
(p. 894).  No other demographic information on the sample was provided.  Extensive 
validation studies of the BAI were conducted on this group of individuals.  
The developers of the BAI used an initial item pool of 86 items to measure 
anxiety as part of the new BAI measure.  The items included were taken from the 
Anxiety Checklist (ACL), Physician’s Desk Reference (PDR) Checklist, and the 
Situational Anxiety Checklist (SAC), all developed by Aaron T. Beck.  The items from 
the ACL evaluated severity of anxiety in depressed patients, reflecting somatic, affective, 
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and cognitive symptoms characteristic of anxiety but not depression.  The PDR Checklist 
was included to serve as a control on item selection.  The SAC was used to evaluate the 
specificity of the anxiety symptoms.  In the clinical evaluation of the participants, the 
researchers used the Structured Clinical Interview for DSM-III (SCID) to aid in 
diagnosis.  The criterion measures used were the Hamilton Rating Scales for Anxiety and 
Depression, the Beck Depression Inventory (BDI), the Hopelessness Scale (HS), and the 
Cognition Checklist (CCL) (Beck et al., 1988). 
Because of the similarity between items, 20 of the initial items were removed 
from the item pool.  Principal factor analyses led to the removal of an additional 19 items.  
After further reliability and validity tests, the final item pool remained at 21 items.  Each 
item describes a common symptom of anxiety and asks the respondent to evaluate 
symptom severity over the past seven days, including the current day. The response scale 
is a 4-point scale, 0 (not at all) to 3 (severely-I could barely stand it).  The items are 
summed to arrive at a final score (0-63) (Beck et al., 1988). 
The researchers tested the reliability of the scale, performed factor analyses, and 
evaluated the convergent and discriminant validity of the final scale.  The final results of 
the evaluation of the BAI revealed that the test has high internal consistency and test-
retest reliability and good concurrent and discriminant validity.  The final scale had a 
high internal consistency (α = .92) and item-total correlations ranging from .30 to .71 
(median = .60).  The test-retest correlation between intake and one week was .75.  After 
performing an iterated principal factor analysis, the researchers found that the first factor 
was comprised of somatic symptoms, while the second factor was comprised of 
subjective anxiety and panic symptoms.   
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Finally, the researchers tested the ability of the BAI to discriminate between three 
diagnostic groups.  The first group was comprised of individuals with anxiety but no 
secondary depression and depression without secondary anxiety.  The second group 
included individuals diagnosed with either depression or anxiety (no secondary diagnoses 
were specified).  Finally, the third comparison group included individuals who had been 
diagnosed with a primary or secondary anxiety disorder and depressed patients with no 
anxiety.  The control group had neither depression nor anxiety.  One-way analysis of 
variance tests revealed that the mean BAI score was higher in the anxious group in 
comparison to the depressed and control groups.  The correlations of the BAI with the 
Hamilton scale for anxiety and the Hamilton scale for depression were .51 and .25, 
respectively.  The correlation of the BAI and BDI was .48.  Finally, the BAI was 
correlated with CCL-A (anxiety) and the CCL-D (depression).  The correlations were .51 
and .22, respectively.  The BAI was also not correlated with the HS (r = .15).  Based on 
this evaluation, the BAI appears to be a valid and reliable measure of anxiety symptom 
severity.  Cronbach’s alpha for BAI scores in the current study was .90. 
Health-related quality of life.  The CRQ is a 20-item disease-specific measure of 
HRQOL that has been used frequently to measure HRQOL in patients suffering from 
COPD.  As such, this scale was only administered to participants with COPD.  Items are 
scored on a 7-point Likert-type scale and measure four domains including dyspnea, 
fatigue, emotional functioning, and disease mastery; higher scores indicate higher levels 
of HRQOL.  The total score indicates better HRQOL.  Items measuring fatigue, emotion, 
and mastery have been found to be highly internally consistent (α = .71-.88).  Test-retest 
53 
 
reliability is also high (p > .90).  The test has been shown to be related to the Symptom 
Checklist-90 (SCL-90) (Wijkstra et al., 1994).   
Rutten-van Mölken, Roos, and Van Noord (1999) conducted a validity study 
comparing the CRQ to the St. George’s Respiratory Questionnaire (SGRQ), another 
disease-specific measure of HRQOL for those with lung disease.  Their study included 
144 patients with moderate to severe COPD and evaluated the patients prior to and after 
12 weeks of treatment.  The researchers found that the CRQ had good internal validity (α 
= .84) and determined that the SGRQ and CRQ could be used interchangeably to measure 
HRQOL in patients with lung disease.  Cronbach’s alpha for CRQ scores in the current 
study was .85 (COPD group only).  
Spirituality.  The FACIT-Sp is a 23-item measurement tool designed to assess 
aspects of spirituality such as meaning in life, harmony, and a sense of strength and 
comfort from one’s faith, all of which are deemed components of HRQOL in individuals 
with chronic illnesses.  Peterman, Fitchett, Brady, Hernandez, and Cella (2002) 
conducted validation and reliability studies on the FACIT-Sp using 1,617 participants 
(53% female and 47% male), most of who had been diagnosed with cancer (83.1%).  
Three ethnicities were represented; 31.1% were African American, 44.4% were Latino, 
and 24.5% were European American.  Most (59.1%) spoke English as a preferred 
language.  No other demographic data was presented.  Participants in the study by 
Peterman and colleagues completed the following measures: Functional Assessment of 
Cancer Therapy-General (FACT-G), Functional Assessment of Chronic Illness Therapy-
Spirituality Well-Being Scale (FACIT-Sp), Marlowe-Crowne Social Desirability Scale 
(MCSDS), and the Profile of Mood States– Short Form (POMS-SF).  The authors 
54 
 
determined that the reliability of the total scale was good (α = .81-.88), indicating good 
internal consistency.  Also, the researchers were able to establish convergent validity, 
determining that the FACIT-Sp was related to measures of organizational religious 
activities (ORA), non-organizational religious activities (NORA), and the Spiritual 
Beliefs Inventory (SBI).  They determined that the FACIT-Sp was moderately correlated 
with NORA and SBI (r = .31 and .48, respectively; p < .0005), indicating that the 
FACIT-Sp is a reliable and moderately valid tool that may be used to assess spirituality in 
individuals with chronic illnesses.  They also found moderate to strong correlations 
between the FACIT-Sp score and QOL (measured by the total FACT-G).  The 
Meaning/Peace (r = .62) and Faith (r = .34) subscales of the FACIT-Sp (r = .58) and the 
FACT-G were positively correlated.  The low relationship between the FACIT-Sp and a 
measure of depression illustrates divergent validity (r = -.54), as do the weak associations 
of the FACIT-Sp and a social desirability scale (r = .27).   
 Peterman and colleagues (2002) also conducted another study in which they 
compared the FACIT-Sp with the SBI.  They found that faith subscale of the FACIT-Sp 
was correlated with the SBI total score (r = .75, p < .005), the SBI Beliefs subscale (r = 
.74, p < .005).  Based on these findings, the FACIT-Sp is psychometrically sound.  
Cronbach’s alpha for FACIT-Sp scores in the current study was .86.  
Functional independence.  FIM is an 18-item measurement tool designed to 
evaluate level of functional independence.  The FIM scale assesses level of cognitive and 
physical functional independence, indicates level of disability or burden of care, and is 
comprised of 18 items in self-care, sphincters, mobility, communication, psychosocial, 
and cognitive domains.  Self-care items include eating, grooming, bathing/showering, 
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upper body dressing, lower body dressing, and toileting.  Sphincter items include bowel 
and bladder management.  Mobility items include bed/chair/wheelchair transfers, toilet 
transfers, bathtub/shower transfers, walking/wheelchair locomotion, and stair locomotion.  
Cognitive items include comprehension, expression, problem solving, social interaction, 
and memory. Scores on each item range from 0 to 7 and are based on level of 
independence in managing the various items included in the FIM.  A score of 1 on a scale 
indicates total dependence while a score of 7 on a scale indicates complete independence.  
A score of 0 indicates the item was not completed.  
FIM is a widely used tool in rehabilitation facilities; an estimated 60% of 
rehabilitation hospitals in the United States utilize the tool (Stineman et al., 1996).  FIM 
has been extensively researched, used with pulmonary populations (Pasqua et al., 2009), 
and is considered to be psychometrically sound.  The study conducted by Pasqua and 
collaborators (2009) involved a cross-sectional analysis of patient records, utilizing factor 
analysis and techniques of multi-trait scaling to verify the summative properties of the 
motor and cognitive dimensions of the FIM and to study the statistical properties of 
admission FIM scores.  In a study of 93,829 patients discharged from freestanding 
rehabilitation hospitals, Stineman and colleagues (1996) found item internal consistency 
to be 96.6% and item discriminant validity to be 100%.  Also, the researchers found 
reliability coefficients for each impairment category ranged from .86 to .97.  These 
findings indicate that the FIM is a good measure of functional independence in patients 
with a variety of health conditions.  Cronbach’s alpha for FIM scores in the current study 
was .96.  
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Depression.  The GDS (see Appendix A) is a public domain, 30-item 
questionnaire in which participants are asked to respond yes or no to questions about 
depressive symptoms, according to how they have felt over the past week.  To protect 
against response sets, some of the items on the GDS are reverse scored.  The scale was 
first developed by Yesavage and colleagues (1983) to demonstrate the applicability of 
depression scales in the elderly population.  The developers chose a pool of 100 
participants who were shown to be more depressed than the normal population to 
determine the items to include in the measure.   
A number of validation studies have been completed on the GDS.  One such study 
included two groups of participants (n = 40 and n = 60).  The first group had no 
psychiatric symptoms.  The second group was undergoing treatment for depression.  The 
latter group was further separated into two groups in terms of mild and severe depression 
based on a predetermined set of criteria.  All participants underwent a clinical interview 
and were administered the Hamilton Rating Scale for Depression (HRS-D), the Zung 
Self-Rating Depression Scale (SDS), and the GDS.  Results for internal consistency, 
reliability, and validity were presented.  The correlation with the total score was .56, 
suggesting that the GDS does, in fact, measure depression.  In terms of inter-item 
correlations, the mean intercorrelation for the GDS was .36; the alpha coefficient for the 
GDS was .94.  Both values indicate high internal consistency.  The split-half reliability 
reported was .94, and the test-retest reliability was .85.  In terms of validity, the 
researchers conducted an analysis of variance and found that the test accurately 
discriminated between groups of people who were either not depressed or were mildly or 
severely depressed.  Convergent validity was also found between the HRS-D and the 
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SDS.  The correlations between the HRS-D and the SDS and the GDS were .84 and .83, 
respectively (Yesavage et al., 1983). 
Jongenelis and colleagues (2005) conducted a study on the accuracy of the GDS. 
The researchers evaluated elderly nursing home inhabitants from the Netherlands.  They 
found that the GDS had 96.3% sensitivity for major depression and 85.1% for minor 
depression with 69.1% specificity.  Dunn and Sacco (1989) also conducted a validation 
study on the GDS in which they examined 439 community-dwelling older adults in 
Pinellas County, Florida.  The researchers determined that the alpha for the GDS was .91, 
indicating good internal validity. 
The GDS has been widely used as a depression-screening tool for those living 
with COPD (Almagro et al., 2002; Kim et al., 2000; Peruzza et al., 2003).  Several 
researchers have also utilized the GDS with older adults in medical settings.  Lyness and 
colleagues (1997) found the GDS yielded a sensitivity of 100% and a specificity of 84% 
in adults 60 years or older who were attending primary care facilities.  Olin, Schneider, 
Eaton, Zemansky, and Pollock (1992) also found the GDS to be sensitive (100%) and 
specific (96%) in detecting depression in older adults in outpatient settings.  Additionally, 
Rapp, Parisi, Walsh, and Wallace (1988) conducted a study on men and found the GDS 
to be one of the most useful tools in detecting depression in the medically-ill elderly in 
terms of reliability (.92), validity, and efficiency, with sensitivity and specificity values of 
70% and 89%, respectively.  Parmelee, Lawton, and Katz (1989) also found that the GDS 
is a good measure for detecting depression in men and women in long-term care 
facilities.  Based on this evidence, using the GDS with men and women with COPD in an 
acute IRF setting would be appropriate and efficient.  Cronbach’s alpha for GDS scores 
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in the current study was .70.  The Cronbach coefficient alpha calculations for the study 
measures are listed in Table 4.   
Table 4 
Cronbach Coefficient Alpha Calculations for Study Measures  
Measure  Alpha  Number of Items  
GDS  0.70  30 
BAI  0.90  21 
FIM  0.96  18 
CRQ  0.85  20 
FACIT-Sp  0.86  12 
 
Study Design 
 The current study employed a cross-sectional design and use of archival data.  
Cross-sectional studies are common in social sciences and survey research; such designs 
are less prone to control effects (Cohen, Manion, & Morrison, 2007).  The goal of 
researchers conducting cross-sectional studies is to describe a pattern of relation between 
variables.  Another advantage to cross-sectional designs is that these designs are carried 
out in natural settings and allow for the use of probability samples; thus, utilizing a cross-
sectional study design allows researchers to make broad statistical inferences and 
generalize findings to real-life situations.  As well, the current study was exploratory in 
nature, as few studies on COPD patients in IRF settings exist in the literature.   
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Table 5 
Summary Table of Research Hypotheses, Statistical Hypotheses, Instrumentation, and 
Analyses 
Research Hypothesis Statistical 
Hypothesis 
Instrumentation Analyses 
1. IRF patients with COPD 
differ in terms of levels of 
depression when compared to 
IRF patients without COPD. 
H0: µnonCOPD = 
µnonCOPD 
 
H1: µnonCOPD ≠ 
µnonCOPD 
GDS Independent 
samples t-test 
2. IRF patients with COPD 
differ in terms of levels of 
anxiety when compared to IRF 
patients without COPD.  
H0: µnonCOPD = 
µnonCOPD 
 
H1: µnonCOPD ≠ 
µnonCOPD 
BAI Independent 
samples t-test 
3. IRF patients with COPD 
differ in terms of level of 
functional independence when 
compared to IRF patients 
without COPD.  
H0: µnonCOPD = 
µnonCOPD 
 
H1: µnonCOPD ≠ 
µnonCOPD 
FIM Independent 
samples t-test 
4. IRF patients with COPD 
differ in terms of level of 
spirituality when compared to 
IRF patients without COPD. 
H0: µnonCOPD = 
µnonCOPD 
 
H1: µnonCOPD ≠ 
µnonCOPD 
FACIT-Sp Independent 
samples t-test 
5. Women with COPD in an 
IRF differ in terms of HRQOL 
in comparison to men with 
COPD in an IRF. 
H0: µwomenCOPD 
= µmenCOPD 
 
H1: µwomenCOPD 
≠ µmenCOPD 
CRQ Independent 
samples t-test 
6. Spirituality mediates the 
relationship between anxiety 
and HRQOL in IRF patients 
with COPD. 
 BAI 
CRQ 
FACIT-Sp 
Mediation; 
indirect macro 
7. Spirituality mediates the 
relationship between depression 
and HRQOL in IRF patients 
with COPD. 
 CRQ 
GDS 
FACIT-Sp 
Mediation; 
indirect macro 
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Table 5 (continued)    
8. Spirituality mediates the 
relationship between anxiety 
and functional independence in 
IRF patients.  
 BAI 
FACIT-Sp 
FIM 
Mediation; 
indirect macro 
9. Spirituality mediates the 
relationship between depression 
and functional independence in 
IRF patients.  
 GDS 
FACIT-Sp 
FIM 
Mediation; 
indirect macro 
10. Gender moderates the 
relationship between anxiety 
and HRQOL in IRF patients 
with COPD. 
 BAI 
CRQ 
 
Moderation; 
hierarchical 
regression 
11. Gender moderates the 
relationship between depression 
and HRQOL in IRF patients 
with COPD. 
 CRQ 
GDS 
 
Moderation; 
hierarchical 
regression 
12. Gender moderates the 
relationship between spirituality 
and HRQOL in IRF patients 
with COPD. 
 CRQ 
FACIT-Sp 
Moderation; 
hierarchical 
regression 
13. Gender moderates the 
relationship between anxiety 
and functional independence in 
IRF patients with COPD.  
 BAI 
FIM 
Moderation; 
hierarchical 
regression 
14. Gender moderates the 
relationship between depression 
and functional independence in 
IRF patients with COPD.  
 GDS 
FIM 
Moderation; 
hierarchical 
regression 
15. Gender moderates the 
relationship between spirituality 
and functional independence in 
IRF patients with COPD.  
 FACIT-Sp 
FIM 
Moderation; 
hierarchical 
regression 
16. Gender moderates the 
relationship between anxiety 
and functional independence in 
IRF patients.  
 BAI 
FIM 
Moderation; 
hierarchical 
regression 
17. Gender moderates the 
relationship between depression 
and functional independence in 
IRF patients.  
 GDS 
FIM 
Moderation; 
hierarchical 
regression 
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Table 5 (continued)    
18. Gender moderates the 
relationship between spirituality 
and functional independence in 
IRF patients.  
 FACIT-Sp 
FIM 
Moderation; 
hierarchical 
regression 
Note. COPD = chronic obstructive pulmonary disease, GDS = Geriatric Depression 
Scale, BAI = Beck Anxiety Inventory, FIM = Functional Independence Measure, FACIT-
Sp = Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being subscale, 
HRQOL = health-related quality of life, CRQ = Chronic Respiratory Questionnaire  
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Chapter Three: Results 
The purpose of the current study was to gain a more complete understanding of 
the BPS relationship between COPD, depression, anxiety, spirituality, HRQOL, 
functional independence, and gender in IRF patients with COPD.  Results of the 
empirical analyses performed on the data are presented in this chapter.  The analyses and 
results are presented in the following sections: descriptive statistics and correlation 
coefficients; analyses; and a summary of key findings. 
Research Hypotheses  
Several research and statistical hypotheses were tested within the current study 
and are listed below. 
Hypothesis 1.  IRF patients with COPD differ in terms of levels of depression 
when compared to IRF patients without COPD. 
Hypothesis 2.  IRF patients with COPD differ in terms of levels of anxiety when 
compared to IRF patients without COPD. 
Hypothesis 3.  IRF patients with COPD differ in terms of level of functional 
independence when compared to IRF patients without COPD. 
Hypothesis 4.  IRF patients with COPD differ in terms of level of spirituality 
when compared to IRF patients without COPD. 
Hypothesis 5.  Women with COPD in an IRF differ in terms of HRQOL in 
comparison to men with COPD in an IRF. 
Hypothesis 6.  Spirituality mediates the relationship between anxiety and 
HRQOL in IRF patients with COPD. 
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Hypothesis 7.  Spirituality mediates the relationship between depression and 
HRQOL in IRF patients with COPD. 
Hypothesis 8.  Spirituality mediates the relationship between anxiety and 
functional independence in IRF patients. 
Hypothesis 9.  Spirituality mediates the relationship between depression and 
functional independence in IRF patients. 
Hypothesis 10.  Gender moderates the relationship between anxiety and HRQOL 
in IRF patients with COPD. 
Hypothesis 11.  Gender moderates the relationship between depression and 
HRQOL in IRF patients with COPD. 
Hypothesis 12.  Gender moderates the relationship between spirituality and 
HRQOL in IRF patients with COPD. 
Hypothesis 13.  Gender moderates the relationship between anxiety and 
functional independence in IRF patients with COPD. 
Hypothesis 14.  Gender moderates the relationship between depression and 
functional independence in IRF patients with COPD.  
Hypothesis 15.  Gender moderates the relationship between spirituality and 
functional independence in IRF patients with COPD.   
Hypothesis 16.  Gender moderates the relationship between anxiety and 
functional independence in IRF patients.  
Hypothesis 17.  Gender moderates the relationship between depression and 
functional independence in IRF patients.  
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Hypothesis 18.  Gender moderates the relationship between spirituality and 
functional independence in IRF patients.  
Data Analyses 
Preliminary analyses.  Descriptive statistics for the study variables in the COPD 
sample are presented in Table 6, and descriptive statistics for the study variables in the 
IRF sample are presented in Table 7.  Descriptive statistics for the study variables in the 
non-COPD sample are presented in Table 8.  Pearson product-moment intercorrelations 
were conducted to determine the strength of the relationships between the variables.  The 
Pearson product-moment intercorrelations for the variables in the COPD sample in the 
current study are presented in Table 9.  The Pearson product-moment intercorrelations for 
the variables in the IRF sample in the current study are presented in Table 10.  The 
Pearson product-moment intercorrelations for the variables in the non-COPD sample in 
the current study are presented in Table 11.  
Table 6 
Descriptive Statistics for Study Variables in the COPD Sample (n = 55) 
Variable Mean SD Kurtosis Skewness Range 
Depression 12.38 3.19 .58 .34 0-30 
Anxiety 12.23 11.22 -1.08 -.11 0-63 
Functional 
Independence 
76.87 23.20 -1.24 .12 0-126 
HRQOL 100.10 25.22 -.60 .19 0-140 
Spirituality 76.35 15.50 -.87 1.06 0-92 
Note. HRQOL = health-related quality of life 
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Table 7 
 
Descriptive Statistics for Study Variables in the IRF Sample (n = 136) 
 
Variable Mean SD Kurtosis Skewness Range 
Depression 12.66 3.64 .17 .65 0-30 
Anxiety 10.32 10.65 -.87 .15 0-63 
Functional 
Independence 
75.30 23.63 -.12 .13 0-126 
Spirituality 74.97 14.87 .11 .90 0-48 
 
Table 8 
 
Descriptive Statistics for Study Variables in the Non-COPD Sample (n = 81) 
 
Variable Mean SD Kurtosis Skewness Range 
Depression 12.15 2.52 -.29 .36 0-30 
Anxiety 7.41 7.44 -.53 .31 0-63 
Functional 
Independence 
74.21 24.01 -1.21 .13 0-126 
Spirituality 73.97 14.43 -.22 .82 0-48 
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Table 9 
Pearson Product-Moment Correlation Coefficients for the Study Variables in the  
COPD Sample (n = 55) 
Variable 1 2 3 4 5 6 7 8 
1. HRQOL 1        
2. Anxiety -.60** 1       
3. Depression -.49** .34** 1      
4. Functional 
Independence 
.12 -.08 -.22* 1     
5. Spirituality .48** -.29** -.41** .12 1    
6. Gender -.31 .10 -.06 -.08 .24 1   
7. Age .13 -.31 -.30 -.10 .14 -.06 1  
8. Ethnicity .20 -.08 -.16 -.21 .07 -.11 .13 1 
Note.  HRQOL = health-related quality of life; Hypotheses were two-tailed. 
Note.  **p < .01, *p < .05 
 
Table 10 
Pearson Product-Moment Correlation Coefficients for the Study Variables in the IRF 
Sample (n = 136) 
Variable 1 2 3 4 5 6 7 
1. Anxiety 1       
2. Depression .34** 1      
3. Functional  
Independence 
.08 -.22* 1     
4. Spirituality -.29** -.41** .12 1    
5. Gender .12 -.04 -.08 -.15 1   
6. Age -.26 -.17 .00 .18 -.11 1  
7. Ethnicity -.08 -.15 -.00 .16 -.07 -.05 1 
Note. Hypotheses were two-tailed. 
Note.  **p < .01, *p < .05 
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Table 11 
Pearson Product-Moment Correlation Coefficients for the Study Variables in the Non-
COPD Sample (n = 81) 
Variable 1 2 3 4 5 6 7 
1. Anxiety 1       
2. Depression .34** 1      
3. Functional  
Independence 
-.08 -.22* 1     
4. Spirituality -.29** -.41** .12 1    
5. Gender .10 -.06 -.08 .24 1   
6. Age -.25 -.10 .05 .21 -.12 1  
7. Ethnicity -.06 -.14 .10 .22 -.04 -.11 1 
Note. Hypotheses were two-tailed. 
Note.  **p < .01, *p < .05 
 
A power analysis to determine appropriate sample size was also conducted prior 
to completing any further data analysis.  The analysis was completed using G*Power 
(Faul, Erdfelder, Lang, & Buchner, 2007).  Results from the analysis indicated that for a 
small effect size (d = .20), a total sample size of n = 651 per group was needed for the t-
tests.  For medium (d = .50) and large effect sizes (d = .80), sample sizes of n = 105 and n 
= 42 per group were needed for two-tailed t-tests.  For one-tailed t-tests, a power analysis 
revealed that for small effect size (d = .20), a total sample size of n = 542 per group was 
needed for the t-tests.  For medium (d = .50) and large effect sizes (d = .80), sample sizes 
of n = 88 and n = 35 per group were needed.  Other power analyses indicated that for a 
small effect size (f2 = .02), a sample size of n = 776 was needed.  For medium (f2 = .15) 
and large effect sizes (f2 = .35), sample sizes of n = 107 and n = 48 were needed, 
respectively for the regression analyses (mediation and moderation).  Since the effect 
sizes in the current study were small at best, power analyses indicated that power was 
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compromised by insufficient sample sizes.  Further preliminary analyses were conducted 
to determine whether age, (t(134) = .48, p = .63), gender (X2 (1, N = 136) = 2.01, p = .22), 
or ethnicity (X2 (1, N = 136) = .64, p = .42) between the COPD and non-COPD groups 
created potential confounds.  Based on results obtained, neither age, gender, nor ethnicity 
is a confounding variable.  The COPD group was comprised of more women than was the 
non-COPD group.  Given the disproportionate number of women in the COPD group, 
bivariate correlations were also conducted to determine whether gender had an effect on 
the outcome variables.  Based on results obtained, gender did not have a significant effect 
on any of the outcome variables in the study (depression, anxiety, functional 
independence, HRQOL, or spirituality).  Results are presented in Tables 9, 10, and 11.  
 Primary analyses.  Independent samples t-tests, mediation, and moderation 
analyses were employed in the current study.  Results from these analyses are described 
in the following sections.  
 Independent samples t-test.  In the current study, independent samples t-tests 
were used to explore (a) differences in levels of depression in individuals with COPD and 
those without COPD, (b) differences in levels of anxiety in individuals with COPD and 
those without COPD, (c) differences in levels of functional independence in those with 
COPD and those without COPD, and (d) differences in levels of HRQOL in men and 
women with COPD.  Regarding depression, no significant differences between the COPD 
(M = 12.38, SD = 3.19) and non-COPD (M = 12.15, SD = 2.52) groups were found; 
t(119) = -.433, p = .67; thus, Hypothesis 1, which stated that patients with COPD differ in 
terms of levels of depression when compared to patients without COPD, was not 
supported.  For anxiety, a significant difference between the COPD (M = 12.23, SD = 
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11.22) and non-COPD (M = 7.41, SD = 7.44) groups was found; t(124) = -2.90, p = .004.  
As such, Hypothesis 2, which stated that patients with COPD differ in terms of levels of 
anxiety when compared to patients without COPD, was supported; patients with COPD 
endorsed higher levels of anxiety than did patients without COPD.  Regarding functional 
independence, no significant differences were found between the COPD (M = 76.87, SD 
= 23.20) and non-COPD (M = 74.21, SD = 24.01) groups; t(130) = -.64, p = .53.  
Therefore, the Hypothesis 3, which stated that patients with COPD differ in terms of level 
of functional independence when compared to patients without COPD, was not 
supported.  Also, when considering levels of spirituality, a significant difference was not 
found between the COPD (M = 76.35, SD = 15.50) and non-COPD groups (M = 73.97, 
SD = 14.43); t(107) = -.08, p = .41.  These results indicate that the Hypothesis 4, which 
stated that patients with COPD differ in terms of levels of spirituality when compared to 
patients without COPD, was not supported.   
An independent samples t-test was also conducted to compare levels of HRQOL 
between men and women with COPD.  The dataset was split such that only individuals 
with COPD were included in the analysis.  A significant difference was found between 
men (M = 112.5, SD = 22.75) and women (M = 95.42, SD = 24.78); t(49) = 2.25, p = .03; 
specifically, women with COPD have lower levels of HRQOL than do men with COPD.  
These results suggest that Hypothesis 5 that stated that men and women with COPD 
differ in terms of levels of HRQOL was supported.  
A review of the literature provided a rationale for utilizing directional hypotheses.  
The current study, however, implemented a more conservative approach and examined 
only non-directional hypotheses.  Statistical analyses of the current study indicate that 
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using directional hypotheses would have also produced nonsignificant results due to the 
size of the p-values obtained.  
Mediation.  A mediation model is used when the analytical goal is to identify and 
explain the underlying process of an observed relationship between an independent and 
dependent variable by including a third or mediator variable.  Mediation establishes how 
or why one variable predicts or causes an outcome variable (Frazier, Tix, & Barron, 
2004) and explains the relationship between the predictor and an outcome (Baron & 
Kenny, 1986).  Essentially, a mediator is the mechanism through which a predictor 
influences an outcome variable (Baron & Kenny, 1986).  A mediation model is often 
chosen when a strong relationship between a predictor and an outcome variable already 
exists.  In the current dissertation, the goal was to utilize mediation to explore the 
following in individuals with COPD in an acute inpatient physical rehabilitation facility 
and in all individuals in an acute inpatient physical rehabilitation facility: (a) whether 
spirituality mediates the relationship between anxiety and HRQOL in patients with 
COPD, (b) whether the spirituality mediates the relationship between depression and 
HRQOL in patients with COPD, (c) whether spirituality mediates the relationship 
between anxiety and functional independence in IRF patients, and (d) whether spirituality 
mediates the relationship between depression and functional independence in IRF 
patients.   
Statistically significant relationships must exist between all variables to conduct 
mediation analyses (Baron & Kenny, 1986).  Pearson-product moment correlations for 
both groups (COPD and IRF) are listed in Tables 9 and 10, respectively.  Those results 
indicate that spirituality was significantly negatively correlated with depression (r = -.41, 
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p < .01) and anxiety (r = .29, p < .01) and positively correlated with HRQOL (r = .48, p < 
.01) in the COPD sample.  The results from these bivariate correlations suggest that (a) as 
spirituality increases, depression decreases in IRF patients with COPD, (b) as spirituality 
increases, anxiety decreases in IRF patients with COPD, and (c) as spirituality increases, 
HRQOL increases in IRF patients with COPD.  Correlations between spirituality, 
anxiety, depression, and functional independence were not statistically significant in the 
IRF patient group. Therefore, mediation analyses were conducted for hypotheses 6 and 7 
but not conducted for hypotheses 8 and 9.  
The mediation macro developed by Preacher and Hayes (2008) was used to 
compute the direct and indirect path coefficients of depression and HRQOL in IRF 
patients with COPD as mediated by spirituality using normalized values.  These path 
coefficients refer to the unstandardized regression weights in the relation of the 
independent and dependent variable.  The independent variable (depression) had a 
significant direct path to the mediator (spirituality, B = -1.13).  The mediator (spirituality) 
also had a significant direct path to the dependent variable (HRQOL, B = 7.91).  
Additionally, depression was found to have a significant indirect effect on HRQOL as 
mediated through spirituality (B = -26.35).  After including spirituality in the model, the 
relation of depression to HRQOL remained significant, indicating that the relationship 
between depression and HRQOL was not fully mediated by spirituality.  Further 
examination of the model revealed partial mediation as indicated by the reduction in the 
path coefficient (B = -26.35 to B = -17.45). The total model was significant (F = 11.75, p 
= .001) and accounted for 40% of the variance in HRQOL.  To further examine the 
significance of the indirect effects, guidelines proposed by Shrout and Bolger (2002) 
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were followed, and 1,000 bootstrap samples using the Preacher and Hayes (2008) indirect 
mediation macro were created.  Across all 1,000 samples, 95% confidence intervals were 
computed for the upper and lower potential limits of these indirect effects.  Shrout and 
Bolger (2002) recommend exploration of the confidence intervals (CI) to determine the 
significance of the indirect effects.  If zero is not included in the range of confidence 
intervals, the indirect effect is said to be significant at the p = .05 level.  Results showed 
that spirituality (SE = 4.76, CI = -22.22, -2.72) does not, in fact, fully mediate the link 
between depression and HRQOL in COPD patients.  Therefore, hypothesis 7 that stated 
spirituality mediates the relationship between depression and HRQOL in IRF patients 
with COPD was partially supported, as results revealed that spirituality partially mediates 
the relationship between depression and HRQOL in IRF patients with COPD.  Table 12 
presents the bootstrap results for the mediation of spirituality in the link between 
depression and HRQOL in COPD patients.  
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Table 12 
Testing Mediator Effects of Spirituality on the Relationship between Depression and 
HRQOL in IRF Patients with COPD 
Depression (IV) to Spirituality (Mediator) (a path) 
 Coefficient  SE t p 
Spirituality -1.13 .34 3.29 .00 
 
     
Direct Effects of Spirituality (Mediator) on HRQOL (DV) (b path) 
 Coefficient  SE t p 
Spirituality  7.91 3.11 2.54 .02 
 
     
Total Effect of Depression (IV) on HRQOL (DV) (c path) 
 Coefficient  SE t p 
Depression  -26.35 6.85 -3.85 .00 
 
     
Direct Effect of Depression (IV) on HRQOL (DV) (c’ path) 
 Coefficient  SE t p 
Depression  -17.45 7.28 -2.40 .02 
Note. HRQOL = health-related quality of life 
The mediation macro developed by Preacher and Hayes (2008) was also used to 
compute the direct and indirect path coefficients of anxiety and HRQOL in IRF patients 
with COPD as mediated by spirituality using normalized values.  These path coefficients 
refer to the regression weights in the relation of the independent and dependent variable.  
The independent variable (anxiety) had a significant direct path to the mediator 
(spirituality, B = -.33).  The mediator (spirituality) did not have a significant direct path to 
the dependent variable (HRQOL, B = 3.90).  Additionally, anxiety was found to have a 
significant indirect effect on HRQOL as mediated through spirituality (B = -7.74).  After 
including spirituality in the model, the relation of anxiety to HRQOL remained 
significant (B = -6.46).  The total model was significant (F = 11.35, p = .0002) and 
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accounted for 39% of the variance in HRQOL.  To further examine the significance of 
the indirect effects, guidelines proposed by Shrout and Bolger (2002) were followed, and 
1,000 bootstrap samples using the Preacher and Hayes (2008) indirect mediation macro 
were created.  Across all 1,000 samples, 95% confidence intervals were computed for the 
upper and lower potential limits of these indirect effects.  Shrout and Bolger (2002) 
recommend exploration of the confidence intervals (CI) to determine the significance of 
the indirect effects.  If zero is included in the range of confidence intervals, the indirect 
effect is said to be nonsignificant at the p = .05 level.  Results showed that spirituality 
(SE = 1.04, CI = -3.33, .85) does not mediate the link between anxiety and HRQOL in 
COPD patients.  Therefore, hypothesis 6 that stated spirituality mediates the relationship 
between anxiety and HRQOL in IRF patients with COPD was not supported.  Table 11 
presents the bootstrap results for the mediation of spirituality in the link between anxiety 
and HRQOL in COPD patients.  
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Table 13 
Testing Mediator Effects of Spirituality on the Relationship between Anxiety and HRQOL 
in IRF Patients with COPD 
Anxiety (IV) to Spirituality (Mediator) (a path) 
 Coefficient  SE t p 
Spirituality -.33 .11 3.07 .00 
 
     
Direct Effects of Spirituality (Mediator) on HRQOL (DV) (b path) 
 Coefficient  SE t p 
Spirituality  .390 2.67 1.46 .15 
 
     
Total Effect of Anxiety (IV) on HRQOL (DV) (c path) 
 Coefficient  SE t p 
Anxiety  -7.74 1.73 -4.46 .00 
 
     
Direct Effect of Anxiety (IV) on HRQOL (DV) (c’ path) 
 Coefficient  SE t p 
Anxiety  -6.46 1.92 -3.37 .00 
Note. HRQOL = health-related quality of life 
 
Moderation.  Moderation analysis addresses “when or for whom a predictor is 
more strongly related to an outcome,” and a moderator variable serves to “alter the 
direction or strength of the relation between a predictor and an outcome…a moderator 
effect is nothing more than an interaction whereby the effect of one variable depends on 
the level of another.” (Frazier et al, 2004, p. 116).  As well, moderation analyses may be 
used when used when the relationship between predictors and outcomes are weak or 
inconsistent.  Baron and Kenny (1986) explain, “it is desirable that the moderator 
variable be uncorrelated with both the predictor and the criterion (the dependent variable) 
to provide a clearly interpretable interaction term” (p. 1174).  In moderation analyses, 
ensuring adequate power is important and depends upon several factors (Frazier et al, 
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2004).  Statistical power in the current study was enhanced by choosing reliable outcome 
variables, ensuring adequate sample sizes, and reliance on theory and information from 
the literature when planning analyses.     
In the current study, several moderation analyses were utilized to evaluate the 
influence of gender in IRF patients.  Specifically, moderation analyses were conducted to 
determine whether gender moderates the relationship between anxiety and HRQOL, the 
relationship between depression and HRQOL, and the relationship between spirituality 
and HRQOL in patients with COPD.  Additionally, moderation analyses were conducted 
to evaluate the impact of gender on the relationship between anxiety and functional 
independence, the relationship between depression and functional independence, and the 
relationship between spirituality and functional independence in patients with COPD.  
Finally, further moderation analyses were conducted to examine the impact of gender on 
the relationship between anxiety and functional independence, the relationship between 
depression and functional independence, and the relationship between spirituality and 
functional independence in IRF patients.  The goal of the moderation analyses was to 
determine whether the effect of anxiety, depression, or spirituality on HRQOL in COPD 
patients was dependent upon gender.  Similarly, another goal of moderation analysis was 
to explore whether the relationship between anxiety, depression, or spiritualty on 
functional independence in COPD patients was dependent upon gender.  A final goal of 
moderation analysis was to determine whether the effect of anxiety, depression, or 
spirituality on functional independence in IRF patients was dependent upon gender.   
Preliminary analyses (bivariate correlations) were conducted to examine the 
strength of the relationship between gender, anxiety, and HRQOL; gender, depression, 
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and HRQOL; and gender, spirituality, and HRQOL in IRF patients with COPD.  
Analyses were also conducted to examine the strength of the relationship between 
gender, anxiety, and functional independence; gender, depression and functional 
independence; and gender, spirituality, and functional independence in COPD patients.  
Final preliminary analyses were conducted to examine the strength of the relationship 
between gender, anxiety, and functional independence; gender, depression, and 
functional independence; and gender, spirituality, and functional independence in IRF 
patients.  The preliminary analyses were conducted as “moderator effects are best 
detected when the relation between the predictor and outcome is substantial.  However, 
moderators often are examined when there are unexpectedly weak relations between a 
predictor and outcome” (Frazier et al, 2004, p. 118).  
In accordance with Aiken and West’s (1991) suggestions for moderation analysis, 
further preliminary analyses were conducted, and the predictor (anxiety, depression, and 
spirituality) and moderation (gender) variables were standardized.  Standardizing 
variables may be preferable to centering variables, because standardizing variables leads 
to easier interpretation of the effects of the predictor and moderator variables (Frazier et 
al, 2004).  Preliminary inspection of the data checked assumptions underlying regression 
analysis including issues of normality, linearity, and homoscedasticity.  Examination of 
scatterplot matrixes revealed that assumptions of normality and homoscedasticity were 
met.  The Durbin-Watson statistic assessed independence and revealed normal values at 
2.0, which is acceptable according to Field (2009).  Variance inflation factors (VIF) were 
assessed, revealing no values over 3, therefore, indicating no issues of multicollinearity.  
Potential influential outliers within the data were analyzed (Bollen & Jackman, 1990).  
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No data points had a Mahalanobis distance greater than 21.47 (Stevens, 2002) or a Cook 
D value greater than 1.   
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which anxiety and gender predict HRQOL in COPD patients.  
The analysis also explored a possible interaction between anxiety and gender to 
determine whether gender moderated the relationship between anxiety and HRQOL in 
COPD patients.  Initially, an interaction term between anxiety and gender was created.  
Standardized predictor variables (anxiety and gender) were entered in step 1, and 
HRQOL was entered as the dependent variable.  Results revealed that anxiety and gender 
explain 43% of the variance in HRQOL in COPD patients. After entry of the interaction 
term of gender*anxiety at step 2, the total variance explained by the model as a whole 
was 46%, R squared change = .03, F change (1, 44) = 1.78, p = .19. Hypothesis 10 stated 
that gender moderates the relationship between anxiety and HRQOL in COPD patients. 
Results from the current study indicate that gender does not moderate the relationship 
between anxiety and HRQOL in IRF patients with COPD. Results from the hierarchical 
regression analysis for anxiety, gender, and HRQOL in COPD patients are presented in 
Table 14. 
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Table 14 
Summary of Hierarchical Regression Analysis for Anxiety, Gender, and HRQOL in IRF 
Patients with COPD (n = 55) 
 Variable B SEB β t p R2 
 
Step 1  
 
Anxiety 
 
-14.09 
 
2.71 
 
-.59 
 
-5.21 
 
.00 
 
  
Gender 
 
-7.19 
 
3.03 
 
-.27 
 
-2.38 
 
.32 
 
.43 
 
Step 2 
 
Anxiety 
 
-14.58 
 
2.71 
 
-.61 
 
-5.39 
 
.00 
 
  
Gender 
 
-7.55 
 
3.01 
 
-.28 
 
-2.51 
 
.31 
 
  
Gender*Anxiety 
 
3.82 
 
2.86 
 
.15 
 
1.34 
 
.34 
 
.46 
   
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which depression and gender predict HRQOL in COPD patients.  
The analysis also explored a possible interaction between depression and gender to 
determine whether gender moderated the relationship between depression and HRQOL in 
COPD patients.  Initially, an interaction term between depression and gender was created.  
Standardized predictor variables (depression and gender) were entered in step 1, and 
HRQOL was entered as the dependent variable.  Results revealed that depression and 
gender explain 35% of the variance in HRQOL in COPD patients. After entry of the 
interaction term of gender*depression at step 2, the total variance explained by the model 
as a whole was 37%, R squared change = .02, F change (1, 43) = 1.52, p = .22. 
Hypothesis 11 stated that gender moderates the relationship between depression and 
HRQOL in COPD patients. Results from the current study indicate that gender does not 
moderate the relationship between depression and HRQOL in COPD patients in an IRF. 
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Results from the hierarchical regression analysis for depression, gender, and HRQOL in 
COPD patients are presented in Table 15.   
Table 15 
Summary of Hierarchical Regression Analysis for Depression, Gender, and HRQOL in 
IRF Patients with COPD (n = 55) 
 Variable B SEB β t p R2 
 
Step 1  
 
Depression 
 
-11.83 
 
2.85 
 
-.51 
 
-4.14 
 
.00 
 
  
Gender 
 
-8.71 
 
3.28 
 
-.32 
 
-2.65 
 
.30 
 
.35 
 
Step 2 
 
Depression 
 
-11.90 
 
2.84 
 
-.51 
 
-4.19 
 
.00 
 
  
Gender 
 
-8.88 
 
3.27 
 
-.33 
 
-2.72 
 
.32 
 
  
Gender*Depression 
 
3.54 
 
2.87 
 
.15 
 
1.24 
 
.22 
 
.37 
   
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which spirituality and gender predict HRQOL in COPD patients.  
The analysis also explored a possible interaction between spirituality and gender to 
determine whether gender moderated the relationship between spirituality and HRQOL in 
COPD patients.  Initially, an interaction term between spirituality and gender was 
created.  Standardized predictor variables (spirituality and gender) were entered in step 1, 
and HRQOL was entered as the dependent variable.  Results revealed that spirituality and 
gender explain 27% of the variance in HRQOL in COPD patients. After entry of the 
interaction term of gender*spirituality at step 2, the total variance explained by the model 
as a whole was 27%, R squared change = .00, F change (1, 37) = .05, p = .83. Hypothesis 
12 stated that gender moderates the relationship between spirituality and HRQOL in 
COPD patients. Results from the current study indicate that gender does not moderate the 
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relationship between spirituality and HRQOL in COPD patients in an IRF. Results from 
the hierarchical regression analysis for spirituality, gender, and HRQOL in COPD 
patients are presented in Table 16.    
Table 16 
Summary of Hierarchical Regression Analysis for Spirituality, Gender, and HRQOL in 
IRF Patients with COPD (n = 55) 
 Variable B SEB β t p R2 
 
Step 1  
 
Spirituality 
 
11.22 
 
3.73 
 
.43 
 
3.01 
 
.01 
 
  
Gender 
 
-5.23 
 
3.87 
 
-.19 
 
-1.35 
 
.20 
 
 
.27 
 
Step 2 
 
Spirituality 
 
11.90 
 
4.95 
 
.46 
 
2.40 
 
.02 
 
  
Gender 
 
-4.64 
 
4.80 
 
-.17 
 
-.97 
 
.34 
 
  
Gender*Spirituality 
 
-1.35 
 
6.33 
 
-.04 
 
-.21 
 
.83 
 
.27 
 
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which anxiety and gender predict functional independence in 
COPD patients.  The analysis also explored a possible interaction between anxiety and 
gender to determine whether gender moderated the relationship between anxiety and 
functional independence in COPD patients.  Initially, an interaction term between anxiety 
and gender was created.  Standardized predictor variables (anxiety and gender) were 
entered in step 1, and functional independence was entered as the dependent variable.  
Results revealed that anxiety and gender explain 1% of the variance in functional 
independence in COPD patients. After entry of the interaction term of anxiety*gender at 
step 2, the total variance explained by the model as a whole was 8%, R squared change = 
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.07, F change (1, 47) = 3.44, p = .07. Hypothesis 13 stated that gender moderates the 
relationship between anxiety and functional independence in COPD patients. Results 
from the current study indicate that gender does not moderate the relationship between 
anxiety and functional independence in COPD patients in an IRF. Results from the 
hierarchical regression analysis for anxiety, gender, and functional independence in 
COPD patients are presented in Table 17. 
Table 17 
Summary of Hierarchical Regression Analysis for Anxiety, Gender, and Functional 
Independence in IRF Patients with COPD (n = 55) 
 Variable B SEB β t p R2 
 
Step 1  
 
Anxiety 
 
-.05 
 
.29 
 
-.03 
 
-.18 
 
.86 
 
  
Gender 
 
.19 
 
.32 
 
.09 
 
.61 
 
.55 
 
.01 
 
Step 2 
 
Anxiety 
 
-.02 
 
.28 
 
-.01 
 
-.07 
 
.95 
 
  
Gender 
 
.25 
 
.31 
 
.11 
 
.79 
 
.44 
 
  
Gender*Anxiety 
 
-.55 
 
.30 
 
-.26 
 
-1.85 
 
.50 
 
.08 
 
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which depression and gender predict functional independence in 
COPD patients.  The analysis also explored a possible interaction between depression and 
gender to determine whether gender moderated the relationship between depression and 
functional independence in COPD patients.  Initially, an interaction term between 
depression and gender was created.  Standardized predictor variables (depression and 
gender) were entered in step 1, and functional independence was entered as the dependent 
variable.  Results revealed that depression and gender explain 2% of the variance in 
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functional independence in COPD patients. After entry of the interaction term of 
gender*depression at step 2, the total variance explained by the model as a whole was 
8%, R squared change = .06, F change (1, 46) = 2.85, p = .10. Hypothesis 14 stated that 
gender moderates the relationship between depression and functional independence in 
COPD patients. Results from the current study indicate that gender does not moderate the 
relationship between depression and functional independence in COPD patients in an 
IRF. Results from the hierarchical regression analysis for depression, gender, and 
functional independence in COPD patients are presented in Table 18.   
Table 18 
Summary of Hierarchical Regression Analysis for Depression, Gender, and Functional 
Independence in IRF Patients with COPD (n = 55) 
 Variable B SEB β t p R2 
 
Step 1  
 
Depression 
 
-.24 
 
.28 
 
-.12 
 
-.86 
 
.40 
 
  
Gender 
 
.20 
 
.32 
 
.09 
 
.62 
 
.54 
 
.02 
 
Step 2 
 
Depression 
 
-.25 
 
.27 
 
-.13 
 
-.91 
 
.37 
 
  
Gender 
 
.22 
 
.32 
 
.10 
 
.71 
 
.48 
 
  
Gender*Depression 
 
-.47 
 
.28 
 
-.24 
 
-1.69 
 
.20 
 
.08 
 
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which spirituality and gender predict functional independence in 
COPD patients.  The analysis also explored a possible interaction between spirituality 
and gender to determine whether gender moderated the relationship between spirituality 
and functional independence in COPD patients.  Initially, an interaction term between 
spirituality and gender was created.  Standardized predictor variables (spirituality and 
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gender) were entered in step 1, and functional independence was entered as the dependent 
variable.  Results revealed that spirituality and gender explain 1% of the variance in 
functional independence in COPD patients. After entry of the interaction term of 
gender*spirituality at step 2, the total variance explained by the model as a whole was 
4%, R squared change = .03, F change (1, 39) = 1.34, p = .25. Hypothesis 15 stated that 
gender moderates the relationship between spirituality and functional independence in 
COPD patients. Results from the current study indicate that gender does not moderate the 
relationship between spirituality and functional independence in COPD patients in an 
IRF. Results from the hierarchical regression analysis for spirituality, gender, and 
functional independence in COPD patients are presented in Table 19.    
Table 19 
Summary of Hierarchical Regression Analysis for Spirituality, Gender, and Functional 
Independence in IRF Patients with COPD (n = 55) 
 Variable B SEB β t p R2 
 
Step 1  
 
Spirituality 
 
.006 
 
.35 
 
.003 
 
.02 
 
.99 
 
  
Gender 
 
.19 
 
.36 
 
.09 
 
.09 
 
.60 
 
.01 
 
Step 2 
 
Spirituality 
 
.34 
 
.46 
 
.16 
 
.16 
 
.47 
 
  
Gender 
 
-.10 
 
.44 
 
-.05 
 
-.05 
 
.82 
 
  
Gender*Spirituality 
 
-.68 
 
.58 
 
.58 
 
-.26 
 
.25 
 
.04 
 
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which anxiety and gender predict functional independence in IRF 
patients.  The analysis also explored a possible interaction between anxiety and gender to 
determine whether gender moderated the relationship between anxiety and functional 
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independence in IRF patients.  Initially, an interaction term between anxiety and gender 
was created.  Standardized predictor variables (anxiety and gender) were entered in step 
1, and functional independence was entered as the dependent variable.  Results revealed 
that anxiety and gender explain 1% of the variance in functional independence in COPD 
patients. After entry of the interaction term of gender*anxiety at step 2, the total variance 
explained by the model as a whole was 2%, R squared change = .01, F change (1,120) = 
1.34, p = .24. Hypothesis 16 stated that gender moderates the relationship between 
anxiety and functional independence in IRF patients. Results from the current study 
indicate that gender does not moderate the relationship between anxiety and functional 
independence in IRF patients in an IRF. Results from the hierarchical regression analysis 
for anxiety, gender, and functional independence in IRF patients are presented in Table 
20.    
Table 20 
Summary of Hierarchical Regression Analysis for Anxiety, Gender, and Functional 
Independence in IRF Patients (n = 136) 
 Variable B SEB β t p R2 
 
Step 1  
 
Anxiety 
 
-.18 
 
.19 
 
-.09 
 
-.98 
 
.33 
 
  
Gender 
 
-.17 
 
.19 
 
-.08 
 
-.92 
 
 
.36 
 
.01 
 
Step 2 
 
Anxiety 
 
-.19 
 
.19 
 
-.09 
 
-1.02 
 
.31 
 
  
Gender 
 
-.19 
 
.19 
 
-.09 
 
-1.02 
 
.31 
 
  
Gender*Anxiety 
 
.22 
 
.19 
 
.11 
 
1.18 
 
.24 
 
.02 
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Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which depression and gender predict functional independence in 
IRF patients.  The analysis also explored a possible interaction between depression and 
gender to determine whether gender moderated the relationship between depression and 
functional independence in IRF patients.  Initially, an interaction term between 
depression and gender was created.  Standardized predictor variables (depression and 
gender) were entered in step 1, and functional independence was entered as the dependent 
variable.  Results revealed that depression and gender explain 23% of the variance in 
functional independence in COPD patients. After entry of the interaction term of 
gender*depression at step 2, the total variance explained by the model as a whole was 
24%, R squared change = .01, F change (1,115) = .58, p = .45. Hypothesis 17 stated that 
gender moderates the relationship between depression and functional independence in 
IRF patients. Results from the current study indicate that gender does not moderate the 
relationship between depression and functional independence in IRF patients in an IRF. 
Results from the hierarchical regression analysis for depression, gender, and functional 
independence in IRF patients are presented in Table 21.    
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Table 21 
Summary of Hierarchical Regression Analysis for Depression, Gender, and Functional 
Independence in IRF Patients (n = 136) 
 Variable B SEB β t p R2 
 
Step 1  
 
Depression 
 
-.44 
 
.19 
 
-.21 
 
-2.36 
 
.40 
 
  
Gender 
 
-.13 
 
.19 
 
-.06 
 
-.69 
 
.54 
 
.23 
 
Step 2 
 
Depression 
 
-.46 
 
.19 
 
-.22 
 
-2.42 
 
.37 
 
  
Gender 
 
-.12 
 
.19 
 
-.06 
 
-.65 
 
.48 
 
  
Gender*Depression 
 
.15 
 
.20 
 
.07 
 
.76 
 
.45 
 
.24 
 
Hierarchical regression analysis (Aiken & West, 1991) was conducted to 
determine the extent to which spirituality and gender predict functional independence in 
IRF patients.  The analysis also explored a possible interaction between spirituality and 
gender to determine whether gender moderated the relationship between spirituality and 
functional independence in IRF patients.  Initially, an interaction term between 
spirituality and gender was created.  Standardized predictor variables (spirituality and 
gender) were entered in step 1, and functional independence was entered as the dependent 
variable.  Results revealed that spirituality and gender explain 16% of the variance in 
functional independence in COPD patients. After entry of the interaction term of 
gender*spirituality at step 2, the total variance explained by the model as a whole was 
17%, R squared change = .01, F change (1, 99) = .03, p = .85. Hypothesis 18 stated that 
gender moderates the relationship between spirituality and functional independence in 
IRF patients. Results from the current study indicate that gender does not moderate the 
relationship between spirituality and functional independence in IRF patients in an IRF. 
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Results from the hierarchical regression analysis for spirituality, gender, and functional 
independence in IRF patients are presented in Table 22. 
Table 22 
Summary of Hierarchical Regression Analysis for Spirituality, Gender, and Functional 
Independence in IRF Patients (n = 136) 
 Variable B SEB Β t p R2 
 
Step 1  
 
Spirituality 
 
.31 
 
.21 
 
.15 
 
1.48 
 
.14 
 
  
Gender 
 
-.23 
 
.21 
 
-.11 
 
-1.09 
 
.28 
 
.16 
 
Step 2 
 
Spirituality 
 
.30 
 
.22 
 
.15 
 
1.36 
 
.18 
 
  
Gender 
 
-.22 
 
.22 
 
-.11 
 
-1.0 
 
.32 
 
  
Gender*Spirituality 
 
.05 
 
.25 
 
-.02 
 
-.19 
 
.85 
 
.17 
 
Summary of Key Findings 
 Several hypotheses were generated for the purpose of the current study and 
included 
• IRF patients with COPD differ in terms of levels of depression when compared to IRF 
patients without COPD.  
• IRF patients with COPD differ in terms of levels of anxiety when compared to IRF 
patients without COPD. 
• IRF patients with COPD differ in terms of level of functional independence when 
compared to IRF patients without COPD.   
• IRF patients with COPD differ in terms of level of spirituality when compared to IRF 
patients without COPD.  
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• Women with COPD in an IRF differ in terms of HRQOL in comparison to men with 
COPD in an IRF. 
• Spirituality mediates the relationship between anxiety and HRQOL in IRF patients with 
COPD. 
• Spirituality mediates the relationship between depression and HRQOL in IRF patients 
with COPD. 
• Spirituality mediates the relationship between anxiety and functional independence in 
IRF patients. 
• Spirituality mediates the relationship between depression and functional independence 
in IRF patients. 
• Gender moderates the relationship between anxiety and HRQOL in IRF patients with 
COPD.  
• Gender moderates the relationship between depression and HRQOL in IRF patients 
with COPD.  
• Gender moderates the relationship between spirituality and HRQOL in IRF patients 
with COPD.  
• Gender moderates the relationship between anxiety and functional independence in IRF 
patients with COPD.  
• Gender moderates the relationship between depression and functional independence in 
IRF patients with COPD.  
• Gender moderates the relationship between spirituality and functional independence in 
IRF patients with COPD.  
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• Gender moderates the relationship between anxiety and functional independence in IRF 
patients. 
• Gender moderates the relationship between depression and functional independence in 
IRF patients with COPD.  
• Gender moderates the relationship between spirituality and functional independence in 
IRF patients with COPD.  
Key findings suggest that few differences between patients with COPD and 
patients without COPD are apparent while both groups are participating in an IRF.  
Specifically, patients with COPD and patients without COPD do not appear to differ with 
respect to levels of depression, spirituality, and functional independence.  Results also 
indicate, however, that patients with COPD differ from non-COPD patients with respect 
to levels of anxiety; specifically, patients with COPD tended to endorse significantly 
higher levels of anxiety than did non-COPD patients.  Additionally, results from 
statistical analyses in the current study indicate that men and women with COPD endorse 
different levels of HRQOL; specifically, men with COPD appear to endorse higher levels 
of quality of life when compared to women with COPD.   
Mediation findings of the current study also indicate that spirituality partially 
mediates the relationship between depression and HRQOL in IRF patients with COPD 
but does not mediate the relationship between anxiety and HRQOL in IRF patients with 
COPD.  As previously mentioned, secondary to non-significant correlations between 
variables, mediation models were not tested to determine whether spirituality mediates 
the relationships between anxiety and functional independence and depression and 
functional independence in IRF patients.  No moderation models tested in the current 
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study were found to be significant.  Specifically, gender does not moderate the 
relationships between anxiety and HRQOL, depression and HRQOL, or spirituality and 
HRQOL in IRF patients with COPD.  Also, gender does not moderate the relationships 
between anxiety and functional independence, depression and functional independence, 
or spirituality and functional independence in IRF patients with COPD.  Finally, gender 
does not moderate the relationships between anxiety and functional independence, 
depression and functional independence, or spirituality and functional independence in 
IRF patients.  A summary of the findings follows in Table 23.  
Table 23 
Alternative Hypotheses and Results 
Alternative Hypothesis Results  
1. IRF patients with COPD differ in terms of levels of 
depression when compared to IRF patients without 
COPD. 
Unsupported  
2. IRF patients with COPD differ in terms of levels of 
anxiety when compared to IRF patients without 
COPD.  
Supported 
3. IRF patients with COPD differ in terms of level of 
functional independence when compared to patients 
without COPD. 
Unsupported  
4. IRF patients with COPD differ in terms of level of 
spirituality when compared to IRF patients without 
COPD.   
Unsupported  
5. Women with COPD in an IRF differ in terms of 
HRQOL in comparison to men with COPD in an IRF. 
Supported 
6. Spirituality mediates the relationship between 
anxiety and HRQOL in IRF patients with COPD. 
Unsupported 
7. Spirituality mediates the relationship between 
depression and HRQOL in IRF patients with COPD. 
Partially supported 
8. Spirituality mediates the relationship between 
anxiety and functional independence in IRF patients. 
Not tested secondary to 
nonsignificant correlations 
between variables 
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Table 23 (continued)  
9. Spirituality mediates the relationship between 
depression and functional independence in IRF 
patients.  
Not tested secondary to 
nonsignificant correlations 
between variables 
10. Gender moderates the relationship between anxiety 
and HRQOL in IRF patients with COPD. 
Unsupported  
11. Gender moderates the relationship between 
depression and HRQOL in IRF patients with COPD. 
Unsupported 
12. Gender moderates the relationship between 
spirituality and HRQOL in IRF patients with COPD. 
Unsupported 
13. Gender moderates the relationship between anxiety 
and functional independence in IRF patients with 
COPD. 
Unsupported 
14. Gender moderates the relationship between 
depression and functional independence in IRF 
patients with COPD. 
Unsupported 
15. Gender moderates the relationship between 
spirituality and functional independence in IRF 
patients with COPD. 
Unsupported 
16. Gender moderates the relationship between anxiety 
and functional independence in IRF patients.  
Unsupported 
17. Gender moderates the relationship between 
depression and functional independence in IRF 
patients. 
Unsupported 
18. Gender moderates the relationship between 
spirituality and functional independence in IRF 
patients. 
Unsupported 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Ronnetta Williams 2013 
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Chapter Four: Discussion 
The purpose of the current study was to investigate the BPS facets of individuals 
receiving treatment for COPD in an acute IRF in Central Kentucky and to evaluate the 
differences between COPD and non-COPD patients in an IRF.  The overall goal of the 
study was multifold.  The research questions used to guide this study were as follows:   
1. How are individuals with COPD in acute IRFs different than IRF patients without 
COPD in terms of mood, functional independence, and spirituality? 
2. How does the HRQOL of women with COPD in acute IRFs differ in comparison to 
HRQOL of men with COPD in acute IRFs? 
3. What is the role of spirituality? Several specific questions are contained within the 
broader question, including:  
a. Does spirituality mediate the relationship between anxiety and HRQOL in IRF 
patients with COPD?  
b. Does spirituality mediate the relationship between depression and HRQOL in 
IRF patients with COPD?  
c. Does spirituality mediate the relationship between anxiety and functional 
independence in IRF patients? And  
d. Does spirituality mediate the relationship between depression and functional 
independence in IRF patients?  
4. What is the impact of gender? Several specific questions are contained within the 
broader question, including:   
a. Does gender moderate the relationship between anxiety and functional 
independence in IRF patients with COPD?  
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b. Does Gender moderate the relationship between depression and functional 
independence in IRF patients with COPD?  
c. Does gender moderate the relationship between spirituality and functional 
independence in IRF patients with COPD?  
d. Does gender moderate the relationship between anxiety and HRQOL in IRF 
patients with COPD?  
e. Does gender moderate the relationship between depression and HRQOL in IRF 
patients with COPD?  
f. Does gender moderate the relationship between spirituality and HRQOL in IRF 
patients with COPD?  
g. Does gender moderate the relationship between anxiety and functional 
independence in IRF patients?  
h. Does gender moderate the relationship between depression and functional 
independence in IRF patients? And  
i. Does gender moderate the relationship between spirituality and functional 
independence in IRF patients?  
A discussion of the results from these research questions is presented in this chapter. 
Differences in Depression, Anxiety, Functional Independence, Spirituality, and 
HRQOL 
 Quantitative findings from the current dissertation suggest that individuals with 
COPD do not differ in terms of levels of depression when compared to those without 
COPD (Hypothesis 1).  This finding is inconsistent with other studies that revealed 
individuals with COPD endorse more depressive symptoms than do those without COPD 
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(e.g., Yohannes et al., 1998).  One reason for such a discrepancy might be due to the 
methodology of the current study.  Researchers have discovered that inpatient physical 
rehabilitation patients often experience symptoms of depression at the beginning of 
treatment, and symptoms tend to wane closer to discharge from the healthcare facility 
(Lieberman et al., 1999), which could be partially due to opportunity for social 
engagement during treatment as well as direct access to biomedical disease treatment.  
Results of the current study may be limited since data were not gathered at one specific 
point in time during admission but rather at various points (admission, midway through 
treatment, and immediately prior to discharge) in time during the patient’s hospital stay.  
Another reason for such a discrepancy might be related to the setting in which the data 
were collected.  Though other researchers have determined that COPD patients are 
typically more depressed than patients with other health conditions (e.g., Yohannes et al., 
1998), most similar studies have been conducted in settings other than IRFs (e.g., Ng et 
al., 2007; Stage et al., 2005; Yohannes et al., 2000).  Therefore, comparisons between the 
results of the current study and the results from other studies on BPS facets of chronic 
disease are limited. 
 Quantitative findings of the current study also revealed that individuals with 
COPD differ in terms of levels of anxiety when compared to those without COPD in 
acute IRFs; specifically, those with COPD have higher rates of anxiety when compared to 
those without COPD (Hypothesis 2).  This finding is consistent with findings from other 
studies which indicate that patients with COPD experience higher rates of anxiety when 
compared to those in the general public (e.g., Brenes, 2003) and studies that suggest that 
those with COPD have higher levels of anxiety when compared to individuals with other 
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health conditions (e.g., Kvaal et al., 2001).  As discussed throughout the current study, 
COPD is a very challenging disease to manage from a BPS perspective.  Many 
physiological symptoms of COPD mimic those of anxiety, particularly panic.  The BAI 
was utilized to evaluate anxiety in the current study.  Researchers have determined that 
though the measure was developed as a tool to assess generalized anxiety, the BAI more 
effectively measures symptoms of panic (Cox, Cohen, Direnfeld, & Swinson, 1996; 
Leyfer, Ruberg, & Woodruff-Borden, 2006).  Findings in the current study that suggest 
patients with COPD endorse higher anxiety than patients without COPD may be a result 
of the use of the BAI and the idea that many physiological symptoms of COPD mimic 
panic symptoms.  
 Additionally, findings in the current dissertation suggest that individuals with and 
without COPD do not differ in terms of levels of functional independence (Hypothesis 3).  
Such a result may be contrary to findings of other researchers who suggest that 
pulmonary rehabilitation serves to decrease disease symptoms and improves health status 
(Paz-Diaz, Montes de Oca, Lopez, & Celli, 2007).  The negative physical impact of 
COPD may have been less for the patients in the study, as they were all already 
participating in a physical rehabilitation program at the time of the data collection.  The 
patients in the current study may have already built physical strength and lung stamina 
and learned to effectively manage the limitations of the disease at the time of the 
assessment, which may improve self-efficacy, reduce stress, and increase emotional well-
being (Bandura, 2010). 
 Also, results from the current study indicate that patients with and without COPD 
do not differ in terms of levels of spirituality (Hypothesis 4).  No studies on the 
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differences between COPD patients and non-COPD patients regarding levels of 
spirituality were found in the review of the literature.  Previous research does, however, 
indicate that endorsement of spirituality and/or participation in religious activities may be 
a protective factor against depression, anxiety, and physical disability in patients with 
COPD (e.g., Burker et al., 2004; Idler & Kasl, 1992), which suggests a BPS effect.  In 
contrast, patients with COPD may endorse higher levels of depression and psychosocial 
disability if these patients conceptualize disease as being a punishment from God (e.g., 
Burker et al., 2004) and may not provide protection from illness and/or disability (e.g., 
Fitchett et al., 1999).  As such, results from the current study indicate the average level of 
spirituality endorsed for both groups was moderately high; thus, the majority of patients 
in the sample appear to consider themselves to be spiritual.  Such results may suggest that 
patients in the hospital may differ in terms of levels of spirituality endorsed when 
compared to individuals who are not hospitalized and/or seeking medical care.  Koenig, 
George, and Titus (2004) obtained similar results in a study that suggested religious 
activities, attitudes, and spiritual experiences are prevalent in hospitalized patients.  
 Finally, quantitative findings do indicate significant differences in levels of 
HRQOL in men and women with COPD in an acute IRF setting (Hypothesis 5).  
Specifically, men with COPD appear to have higher levels of HRQOL than do women 
with COPD.  This finding was consistent with other studies that revealed differences in 
HRQOL in men and women with COPD.  Other researchers have determined that though 
both men and women with COPD experience significant psychological distress as a result 
of having the disease, women appear to suffer more psychologically from the effects of 
COPD and have lower levels of HRQOL in comparison to men (e.g., de Torres et al., 
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2005; DiMarco et al., 2006; Wagena et al., 2005).  One reason for the observed 
differences in HRQOL between men and women with COPD is that women appear to 
have a longer course of illness than do men and thus, suffer the effects of the disease 
longer.  As well, women have also been reported to have more disease exacerbations 
when compared to men (de Torres et al., 2005).  Such findings support the idea that 
chronic disease does not simply have a biological impact on individuals living with them 
but rather affects individuals psychologically as well.   
Another reason for the observed differences in HRQOL between men and women 
with COPD may also be rooted in biology.  Researchers recognize that women and men 
react differently to stress, with women secreting higher levels of stress hormones than do 
men when exposed to stressors.  Also, women appear to report more negative emotions 
(sadness, fear, anxiety) in comparison to men.  Finally, from a sociological perspective, 
men have historically been expected to display adequate emotional control and autonomy 
while women have been encouraged to utilize linguistic expression and emphasize 
intimacy (Lee, 2005).  As such, women may be more likely than men to report discomfort 
or unease, whether emotional, social, or physical.  These ideas combined lend further 
BPS evidence for the finding that women with COPD tend to have lower levels of quality 
of life when compared to men with COPD.  
 Research in the current study was conducted in an acute IRF setting.  Findings of 
the study in terms of differences between men and women with and without COPD in 
depression, anxiety, functional independence, spirituality, and HRQOL varied in 
comparison to previous research and are as follows:  
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1. Patients with COPD do not differ in levels of depression, functional independence, or 
spirituality when compared to those without COPD. 
2. COPD patients differ in terms of levels of anxiety when compared to non-COPD 
patients; COPD patients have higher levels of anxiety when compared to those without 
COPD.  
3. Men and women with COPD have different levels of HRQOL; men with COPD 
appear to have higher levels of HRQOL than do women with the disease. 
Spirituality as a Mediating Variable 
Another purpose of the current study on BPS facets of chronic disease involved 
mediation.  Specifically, the goal was to determine whether the degree of spirituality 
mediates the relationships between anxiety and HRQOL and depression and HRQOL in 
IRF patients with COPD as well as the relationships between anxiety and functional 
independence and depression and functional independence in IRF patients.  Quantitative 
findings of the current study revealed spirituality does not mediate the relationship 
between anxiety and HRQOL in IRF patients with COPD (Hypothesis 6).  Regarding 
depression and HRQOL, results indicated a significant negative relationship between 
depression and HRQOL in IRF patients with COPD, suggesting that as depression 
decreases, HRQOL increases, or vice versa.  Further exploration of spirituality as a 
mediator in the relationship between depression and HRQOL in IRF patients with COPD 
revealed that spirituality partially explains the relationship between depression and 
HRQOL in IRF patients with COPD.  As such, IRF patients with COPD and lower levels 
of depression may have higher HRQOL partially due to higher levels of spirituality 
(Hypothesis 7).  These results are consistent with findings from other researchers (e.g., 
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Giaquinto et al., 2010) who identified a significant relationship between mood and 
psychological well-being and recognized that this relationship may be directly influenced 
by spirituality.  The idea that spirituality is the essence of being and allows us to instill 
meaning into and become aware of who we are; “it shapes our life journey” (e.g., Dossey 
et al, 2000, p. 91) may be one reason behind the findings of the current study.  Based on 
this premise, those who espouse spiritual ideology may also be able to derive positive 
meaning from disease, which may foster acceptance and, in turn, serve to positively 
influence the relationship between mood and HRQOL for those living with chronic 
illnesses.  
As mentioned, to conduct mediation analyses, bivariate correlations between the 
variables should be significant to continue with the analyses.  The relationships between 
spirituality, depression, and functional independence were nonsignificant in the IRF 
sample.  Therefore, mediation analyses to test whether spirituality mediates the 
relationship between anxiety and functional independence and the relationship between 
depression and functional independence in IRF patients were not conducted (Hypotheses 
8 and 9).  Such a result is in contrast with findings that suggest depression and anxiety are 
positively correlated (e.g., Cully et al., 2006; Ryu, Chun, Lee, & Chang, 2010) but 
consistent with studies that were unable to find a correlation between depression and 
spirituality (Mystakidou, Tsilika, Parpa, Smyrnioti, & Vlahos, 2007) in patients with 
chronic disease.  The nonsignificant correlation may have been a product of the 
healthcare setting in the current study.  Some researchers have found that inpatient care is 
superior to outpatient care in terms of achieving better clinical outcomes (Anderson, 
Needleman, Gatter, Andrews, & Scarola, 1988; Helewa, Bombardier, Goldsmith, 
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Menchions, & Smythe, 1989; Vliet Vlieland, Breedveld, & Hazes, 1997), which may 
suggest an added benefit of more focused biomedical treatment, opportunity for social 
engagement and thus, reduced negative emotional impact of chronic disease.  
Additionally, researchers have found that patients who have undergone inpatient physical 
rehabilitation have a greater sense of personal control over their conditions when 
compared to those who have not participated in inpatient physical rehabilitation programs 
(Tate & Forchheimer, 2004).  Also, patients who are undergoing similar treatment in the 
same facility may identify with others in the cohort and benefit from having developed a 
sense of community and belongingness (Chipuer & Pretty, 1999; Hill, 1996; McMillan & 
Chavis, 1986), indicating that social aspects of physical rehabilitation programs may 
provide an advantage for those living with chronic diseases.  These results provide 
continued support for the endorsement of the BPS model when treating chronic diseases.  
As mentioned, a variety of reasons may have played a role in the inconclusive results of 
the current study.  Findings of the current study when evaluating spirituality as a 
mediator are as follows:  
1. Spirituality partially mediates the relationship between depression and HRQOL in IRF 
patients with COPD. 
2. Spirituality does not mediate the relationship between anxiety and HRQOL in IRF 
patients with COPD.  
Gender as a Moderating Variable 
 The final goal of the current study was to explore the impact of gender (a 
biological, social, and psychological factor) on IRF patients.  Specifically, the goal was to 
determine whether gender moderates the relationships between anxiety and HRQOL, 
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depression and HRQOL, and spirituality and HRQOL in IRF patients with COPD.  Also, 
a purpose of the current study was to determine whether gender moderates the 
relationships between anxiety and functional independence, depression and functional 
independence, and spirituality and functional independence in IRF patients with COPD.  
The final purpose of the study was to determine whether gender moderates the 
relationships anxiety and functional independence, depression and functional 
independence, and spirituality and functional independence in IRF patients.  Results 
revealed that gender does not moderate any of the aforementioned relationships 
(Hypotheses 10-18).  
 A review of the literature found that results on the moderating impact of gender 
are mixed.  The results of the current study regarding gender are consistent with findings 
from some researchers, which showed that gender does not moderate the relationship 
between mood and disability (e.g., Keogh et al, 2006) but inconsistent with other 
researchers who found that gender does in fact moderate the relationship between mood 
and functional independence as measured by recovery from medical procedures (e.g., 
Dao et al, 2012).  No existing studies on the impact of gender on the relationship between 
spirituality and HRQOL or spirituality and functional independence were found in the 
literature.  
With regard to COPD specifically, researchers have realized the BPS impact of 
the disease and have found that more women than men die from COPD each year (CDC, 
2012), and women tend to endorse and discuss more depressive, anxiety, and physical 
symptoms than do men (e.g., Craske, 2003; Fischer, 1993; Kroenke & Spitzer, 1998).  
This finding may be a primary reason that the sample was primarily comprised of 
103 
 
females, which could have also impacted the results of the research questions that 
evaluated the BPS influence of gender.  Again, such findings may be a result of the 
methodology and the time during admission to the IRF at which data were collected.  
While undergoing rehabilitation, depressive symptoms appear to wane (Lieberman et al., 
1999).  The same may be true for symptoms of anxiety, as one aspect of pulmonary 
rehabilitation is to foster self-management of the disease and another may be a product of 
the social environment inherent in inpatient physical rehabilitation programs.  For those 
with COPD and anxiety, learning to manage the symptoms of COPD may have a BPS 
impact and, thus, may also serve to alleviate the physiological symptoms of anxiety.  
Regarding the influence of gender in IRF patients, results were as follows:  
1. Gender does not moderate the relationship between anxiety and HRQOL in IRF 
patients with COPD. 
2. Gender does not moderate the relationship between depression and HRQOL in IRF 
patients with COPD. 
3. Gender does not moderate the relationship between spirituality and HRQOL in IRF 
patients with COPD. 
4. Gender does not moderate the relationship between anxiety and functional 
independence in IRF patients with COPD. 
5. Gender does not moderate the relationship between depression and functional 
independence in IRF patients with COPD.  
6. Gender does not moderate the relationship between spirituality and functional 
independence in IRF patients with COPD.  
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7. Gender does not moderate the relationship between anxiety and functional 
independence in IRF patients.  
8. Gender does not moderate the relationship between depression and functional 
independence in IRF patients.  
9. Gender does not moderate the relationship between spirituality and functional 
independence in IRF patients.  
Limitations 
 A variety of limitations of the current study are evident and are discussed in the 
following section.   
 Sample limitations.  Several limitations of the study exist and should be 
considered when interpreting the findings and generalizing results to the larger 
population.  Many limitations may be related to the characteristics of the study sample.  
While most of the research questions focused on the COPD section of the sample, 
another goal was to evaluate the differences between the COPD and non-COPD 
participants as well as the IRF group in its entirety.  Though technically adequate for the 
statistical analyses employed in the study, the COPD sample was comprised of 55 
patients.  A larger sample size may better ensure representative distribution of the 
population and be representative of other patients with COPD in acute IRF settings.  A 
higher number of patients without COPD were included in the sample (n = 81) and may 
have skewed the results of the study.   
 Most individuals included in the sample were Caucasian, which indicates a 
potential culture bias.  While health disparities primarily impact minority groups (Straub, 
2002), the CDC (2012) recognizes that more Caucasian individuals die from COPD when 
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compared to non-Caucasian individuals.  According to The Office on Women’s Health 
(2009), Kentuckians have some of the highest rates of death due to chronic disease when 
compared to the rest of the nation.  Statistics from the CDC indicate that while 6.3% of 
Americans report having COPD, approximately 9% of Kentuckians report having the 
disease.  Also according to the CDC, southern states appear to account for the highest 
prevalence of self-reported and physician-diagnosed COPD.  The entire sample was 
comprised of Kentucky residents, which could indicate that people in Kentucky might be 
different in terms of their experience of COPD when compared to non-Kentucky 
residents with COPD.  
 Also regarding the sample, limited demographic information was originally 
collected as part of the dataset and available to the primary investigator.  Such sparse 
demographic data may have limited the scope of potential analyses and thus 
determination of trends and other meaningful relationships among variables and other 
data.  Other data points were not included in the original database, because such data 
points were not included in the original analysis proposal.  Despite the limitations in the 
original proposal, including demographic data such as education, marital status, and so 
forth, might have led to richer understanding of the sample.   
The fact that patients with a variety of conditions were included in the non-COPD 
sample may have also influenced answers provided on questionnaires.  For example, a 
patient with a hip replacement may respond very differently to questions about 
spirituality than would a patient with heart disease or a limb amputation.  Finally, those in 
the sample were all undergoing physical rehabilitation in an acute IRF, which limits 
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generalizability to patients in other healthcare settings and in the community.  In addition 
to sampling limitations, methodology limitations also existed in the current study.  
 Methodology limitations.  Some methodology limitations are apparent in the 
current study.  As mentioned, the study design was cross-sectional and exploratory in 
nature.  Limitations of the use of cross-sectional design include inadequate control of 
extrinsic and intrinsic factors secondary to lack of randomization, which may reduce 
internal validity.  As well, cross-sectional designs do not employ control of independent 
variables and thus do not allow researchers to make valid causal inferences.  As with 
cross-sectional study design, limitations in analysis are also apparent. 
 Generally, independent samples t-test analyses are limited in that the analyses test 
differences between two groups only and are used to examine only the effects of one 
independent variable on one dependent variable.  Such is not an issue in the current 
study, as the study sample was comprised of only two groups, and the analyses included 
only one independent and one dependent variable each.  Therefore, the independent 
samples t-test was deemed to be the most appropriate analysis to conduct to examine 
group differences in the current study.  
 Also, all individuals included in the study were solicited for participation while in 
the hospital and participated on a voluntary basis.  Those who agreed to participate in the 
study may have been different than those who were unwilling to participate.  For 
example, patients who might have endorsed more symptoms of depression and/or anxiety 
may have declined to participate, and patients who do not consider themselves to be 
spiritual and/or religious at all may have also declined to participate.  No information was 
collected from the patients who declined to participate.  Though offered the choice to opt 
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out of the study with no adverse consequences, some individuals may have felt coerced to 
participate.  As well, the study was cross-sectional and exploratory; thus, sample 
selection was not random.  As a result, outside influences may have skewed the results of 
the study, and the cross-sectional design makes establishing causality among study 
variables impossible.   
 Additionally, data were collected from patients in an acute IRF setting in central 
Kentucky only, which limits generalizability to COPD patients in other types of settings, 
especially in programs that provide less opportunity for social engagement, and in other 
geographic locations.  Collecting data in one type of setting limits comparisons to other 
types of settings as well; for example, one cannot conjecture that COPD patients in acute 
IRFs have the same BPS experience as COPD patients in acute care facilities.  Also, data 
may have been collected at various points during the patient’s admission to the facility.  
Such limits in methodology may have skewed results obtained from the current study.  
For example, after learning to adequately manage COPD through exercise and education 
as well as having the opportunity for social engagement with others with similar 
experiences, a COPD patient may endorse fewer symptoms of depression and/or anxiety 
than when the patient first arrives at the facility.  As mentioned, researchers have 
discovered a variety of physical, social, and psychological benefits to participating in 
physical rehabilitation programs (e.g., Paz-Diaz et al., 2007).  All patients in the current 
study were enrolled in a pulmonary rehabilitation program and were solicited for 
participation in the study at various points during their hospital stay.  Soliciting 
participation upon admission, prior to undergoing any treatment, may have yielded 
different results.  
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 Another limitation of the study is that no information was collected on multiple 
admissions.  As mentioned, researchers have discovered that patients with COPD have 
frequent hospital readmissions secondary to symptom exacerbations and, thus, experience 
related psychosocial distress (Cao et al., 2006).  Researchers have discovered lasting 
benefits of rehabilitation programs and have found that resulting improvements may be 
maintained for at least 12 months (Yohannes, Doherty, Bundy, & Yalfani, 2010).  As 
such, those patients who have undergone pulmonary rehabilitation in the past may benefit 
more and/or quicker than those who have not participated in such treatment, which may 
suggest that rehabilitation patients also benefit psychologically from social aspects of 
such programs.  Conversely, individuals with frequent admissions are likely to have 
worse disease severity than those without frequent admissions (e.g., Cao et al., 2006).   
 Instrumentation limitations.  Though deemed psychometrically sound, the 
instruments utilized in the current study have some limitations.  The GDS is considered a 
Gold Standard Rating Scale screening tool for depression (Cusin, Yang, Yeung, & Fava, 
2010) but does not substitute for a thorough diagnostic interview.  Use of a screener only 
is not appropriate for diagnosis of a disorder but may be helpful when determining 
whether an individual is experiencing symptoms of the disorder.  Additionally, the GDS 
does not assess for suicidal ideation (Greenberg, 2012), which may be one indicator of 
depression severity. 
 As with the GDS, the BAI was also developed as a screening tool for anxiety and 
is not a substitute for a clinical interview.  Research indicates that the BAI does not 
effectively assess the cognitive symptoms of anxiety (Wetherell & Gatz, 2005) and “is 
better used as a tool for assessing panic disorder than any other anxiety disorder” (Cox et 
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al., 1996; Leyfer et al., 2006), which may limit the construct validity of the tool.  The 
utility of the BAI with an older population may be even further limited as older adults 
typically experience less autonomic arousal when compared to younger individuals (Lau, 
Edelstein, & Larkin, 2001).  As a result, a patient with panic disorder who elevates the 
BAI may be considered more anxious than a patient without panic-related anxiety (e.g., 
Leyfer et al., 2006).  Additionally, Wetherell and Gatz (2005) discovered that symptoms 
of anxiety are significantly positively correlated with the number of self-reported medical 
conditions in older adults, suggesting that the BAI may overestimate anxiety symptoms 
in a medically ill sample.  Especially with a lung disease such as COPD, which leads to 
shortness of breath, elevations on the BAI may be reflective of somatic symptoms of the 
disease rather than true anxiety.   
 Related to emotional distress is the concept of HRQOL.  The measure used to 
evaluate HRQOL in the current study was the CRQ.  The CRQ is the only measure 
utilized in the study that was normed using a COPD population.   Because the other 
measures have not been normed using individuals with lung disease, utilizing the 
measures to assess those with lung disease may yield different results.  According to 
Glaab, Vogelmeier, and Buhl (2010), the CRQ is limited in that the tool “is less suitable 
for inter-individual comparisons, as it mirrors individual physical limitations.  The 
questionnaire is not interchangeable with other disease-specific instruments and has not 
yet been shown to be responsive to long-term disease progression” (p. 6).   
 Another instrument limitation is related to FIM, which is a measure used to 
evaluate functional independence.  Glenny and Stolee (2009) indicate that though 
typically utilized with older adult populations, few, if any, studies evaluate the 
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psychometric properties of the tool with older adults; in the current study, part of the 
sample was comprised of older adults.  The researchers also propose that FIM items may 
not be appropriate for use with patients in different impairment groups, which suggests 
that the utility of FIM when used with COPD patients may be limited.  
 Limitations may also exist with the FACIT-Sp.  One complication of using a 
measure of spiritual well-being, however, is illustrated by Johnson and colleagues (2011).  
The researchers found that asking about spirituality may increase emotional distress in 
individuals who have had previous negative religious experiences.  Additionally, 
Peterman and colleagues (2002) found that the FACIT-Sp is limited in a number of ways.  
First, demographic differences may skew the results of the FACIT-Sp; thus, the authors 
recommend controlling for factors such as gender and age.  As well, the researchers 
recognize that the total scale and subscale scores differ regarding ceiling effects.  Only 
total scale scores were utilized in the current study.  Also, the FACIT-Sp may not 
adequately address all aspects of spirituality, as many people have varying 
conceptualizations of spirituality.  The researchers specifically noted that the FACIT-Sp 
does not address factors such as forgiveness, generosity, or love.  Other researchers have 
reiterated the idea that the FACIT-Sp is not a measure of only spirituality but also 
addresses spiritual support, which could limit the utility of the measure when the goal is 
to evaluate spirituality in the true sense (e.g., McClain et al., 2003).   
 Also, no specific tool was used to assess the social experience of COPD patients 
in an acute IRF setting; rather, the social component of the BPS model was addressed 
through the evaluation of other factors such as mood and HRQOL.  To wholly evaluate 
the patient’s BPS understanding of COPD, incorporating a specific measure on social 
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interaction and/or other social factors may prove useful.  Though other researchers have 
demonstrated the study measures to be psychometrically sound, the measures are 
structured and objective and do not allow for patients to expound upon their answers; 
thus, such quantitative measures may not have captured the whole experience of the 
patient.  Also, self-report measures pose some limits as well.  
Most tools utilized in the study were self-report measures.  Paulhus and Vazire (as 
cited in Robins, Fraley, Krueger, 2009) stated several disadvantages of using self-report 
measures exist and include “anchoring effects, primacy and recency effects, time 
pressure, and consistency motivation” (p. 229) as well as credibility of the person 
completing the measure, self-deception, self-knowledge, and/or self-awareness 
constraints, the patient’s memory of his or her experience, use of face-to-face interview 
format, impression management, inaccuracies in information provided, self-
consciousness of the interviewee, impression management, transference, modeling, 
socially desirable responding, acquiescent responding, and extreme responding.  As well, 
responses to survey portions of the assessment may have been affected by interviewer 
rapport, respondent anonymity, and psychological and social differences between the 
interviewer and respondent (Gergen & Back, 1966).  Some cultural limitations of self-
report measures also exist, and African Americans may respond differently to questions 
than do Caucasian patients due to concerns such as cultural mistrust (Terrell, Taylor, 
Menzise, & Barrett, 2009).  Barr, Herbstman, Speizer, and Camargo (2002) determined, 
however, that self-report measures are appropriate for use when evaluating those with 
respiratory diseases.  The findings and limitations of the current dissertation have 
implications for future research and practice.  
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Implications of Findings for Future Research and Practice 
 While many researchers have discovered that patients with COPD appear to be 
different than patients without COPD, the current study revealed that IRF patients with 
COPD patients in fact differ from IRF patients without COPD patients in minor ways 
when both groups are participating in an IRF program.  As such, the results have 
implications for both counseling psychology clinical practice and future research in the 
area of the BPS experience of chronic disease, COPD, and inpatient physical 
rehabilitation. 
 Anxiety.  Some results from the current study echo previous findings of other 
researchers and support the idea that IRF patients with COPD are more anxious than IRF 
patients without COPD or people in the general public, at least when evaluated using the 
BAI.  In terms of clinical practice, utilizing empirically validated treatments, such as 
cognitive-behavioral therapy (CBT) techniques, may serve to alleviate the symptoms of 
anxiety experienced by patients with COPD.  Other interventions may include relaxation 
and stress inoculation training.  Implementing a psychoeducation component to 
treatment, either in group or individual format, may also serve to mitigate the symptoms 
of anxiety as well as assist IRF patients in differentiating between the biomedical 
symptoms of COPD and the symptoms of anxiety, as both are very similar.  Counseling 
psychologists may also focus interventions on mindfulness and acceptance of chronic 
disease.    
As previously mentioned, the BAI appears to assess symptoms of panic rather 
than generalized anxiety, and panic symptoms can mimic symptoms of COPD and vice 
versa.  Incorporating a measure that more fully assesses symptoms of generalized anxiety 
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may further contribute to our understanding of anxiety in the COPD patient.  Future 
research may focus on specifically parceling out the differences between the 
physiological versus psychological symptoms of COPD by utilizing a variety of tools 
designed to measure cognitive, physical, and emotional aspects of anxiety.   
 Gender and HRQOL.  As well and in congruence with findings of other 
researchers, the current study supports the idea that women with COPD tend to endorse 
lower levels of HRQOL than do men with COPD while participating in treatment in an 
IRF.  As such, clinicians may take care to implement interventions specifically geared to 
the BPS experiences of women with chronic diseases, educating women on disease self-
management as well as CBT strategies to minimize the biomedical, social, and 
psychological impact of chronic disease.  Incorporating CBT strategies and promoting 
adequate disease self-management may increase self-efficacy and may be used to 
encourage increased physical activity, which may positively influence HRQOL.  
Additionally, educating women on gender differences with respect to chronic diseases 
may serve to enhance women’s understanding of the overall BPS impact of chronic 
disease symptoms.  One approach to further educate women on the BPS experience of 
chronic illnesses may be to hold women only treatment groups in the IRF setting.  Also, 
regarding future research, further examining inpatient gender differences may be 
advantageous to clinicians, as males in inpatient physical rehabilitation settings may be 
different than typical males or males in other types of healthcare settings.  The sample in 
the current study was comprised primarily of female participants.  As such, the typical 
male may not have been well represented in the sample.    
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 As well, incorporating information on the ways men and women communicate 
and express themselves may further elucidate the differences between the two groups; for 
example, men and women may express discomfort in a variety of ways and in contrast to 
one another.  Understanding such differences prior to conducting another study may 
assist researchers in selecting the most appropriate methodological tools and procedures.  
A review of the literature revealed a deficiency in the number of BPS studies on the 
moderating effects of gender on the relationship between COPD and depression or COPD 
and anxiety.  Further research of this type may also serve to supplement our 
understanding of gender and COPD.   
 Spirituality, mood, and HRQOL.  Results of the current study show that 
patients with COPD seem to have minor differences when compared to those without 
COPD with respect to levels of spirituality, a finding that suggests those with progressive 
and irreversible lung disease do not tend to rely on spiritual forms of coping any more or 
less than do those with other types of medical conditions.  Results from the current study 
do, however, indicate that spirituality may partially mediate the relationship between 
depression and HRQOL in patients with COPD; specifically, higher levels of depression 
may lead to lower levels of HRQOL and vice versa in IRF patients with COPD.  Also, 
IRF patients with COPD who endorse higher levels of spirituality may experience less of 
an impact of depressive symptoms on HRQOL.  Conversely, IRF patients with COPD 
who also endorse low levels of spirituality may experience a greater impact of depressive 
symptoms on HRQOL.  Treatment may include incorporating spiritually focused 
interventions for COPD patients in an IRF.  Such interventions may include offering 
chaplain services or treatment groups focused on spiritual content, as well as educating 
115 
 
patients about the impact of spirituality on the experience of chronic disease.  From a 
counseling psychology perspective, an existential treatment approach may prove 
beneficial when working with IRF patients with COPD.  Encouraging IRF patients with 
COPD to discuss the impact spirituality has had on their own disease processes may also 
be advantageous and positively influence HRQOL by alleviating symptoms of 
depression.  Also, since some researchers have determined that the FACIT-Sp does not 
adequately assess spirituality, utilizing another measure to more fully address this factor 
may further supplement the literature. 
Nonsignificant findings.  Specifically and maybe surprisingly, COPD patients 
are actually not significantly different than non-COPD patients in terms of levels of 
depression or functional independence, which suggests that participating in an IRF 
program may minimize or reduce the BPS differences between the two groups or enhance 
certain aspects of the BPS experience for those living with chronic conditions.  Likewise, 
the COPD patient’s level of functional independence does not seem to impact his or her 
HRQOL, at least when the COPD patient is involved in inpatient physical rehabilitation.  
Furthermore, being male or female does not appear to make a difference with respect to 
mood in patients with COPD.  Essentially, much of the current literature suggests that 
COPD patients are significantly more impaired from a BPS perspective when compared 
to those without COPD; the current study declares otherwise, and the results indicate that 
COPD and non-COPD patients may be more alike than previously considered, at least 
while in an IRF.  To supplement the literature on COPD and to further elucidate why IRF 
patients with COPD differ from IRF patients without COPD differ in minor ways, future 
research may focus on resilience and denial to determine whether IRF patients are 
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resilient to the effects of chronic illnesses or whether they are in denial about the severity 
and BPS impact of their health conditions.   
Culture.  Future research in the area of COPD may benefit from incorporating a 
more prominent cultural piece.  As mentioned, the interviewer was female and 
Caucasian, and the database included only Caucasian and African American patients.  
Conducting a more culturally sensitive study and including a variety of interviewers may 
elicit different results.  Also regarding culture, expanding the research to a multitude of 
geographic areas is ideal to be able to generalize results to multiple cultural groups.  
System interventions.  At the macro level, counseling psychologists in the IRF 
setting may further benefit patients by also educating treatment providers on the BPS 
manifestation of COPD and chronic disease in general, especially the experience of the 
IRF patient.  Teaching healthcare providers about the unique needs of IRF patients may 
serve to encourage those typically trained in the medical model to implement more 
holistic and BPS focused treatment interventions.  The overall impact may positively 
impact HRQOL of those living with chronic conditions and further enhance benefits 
gained while patients are in an IRF.  
IRF settings.  One major rationale for completing the current study was to 
supplement the current BPS literature on COPD and to provide further insight into the 
acute pulmonary rehabilitation patient’s BPS disease experience.  Literature on the BPS 
experience of COPD patients in acute physical rehabilitation is scant.  As such, 
conducting more research in this type of setting will serve to foster our understanding of 
the COPD patient’s BPS experience throughout the disease process and in a variety of 
settings and determine whether trends exist.  Also, by completing research in this area, 
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we may come to better understand the benefits of acute inpatient physical rehabilitation 
and the related impact on the psychological, social, and physical experience of the COPD 
patient; as well, we may then compare patients in acute IRFs to those in other healthcare 
venues such as acute care, outpatient, and community settings.   
 Method.  Based on the findings and limitations of the current study, using a more 
structured method when gathering data may serve to elicit different results.  Future 
researchers may benefit from collecting data at more specific time intervals throughout 
the COPD patient’s IRF admission.  Conducting interviews at admission, halfway 
through the patient’s hospital stay, and at discharge may capture a more complete 
representation of the COPD patient’s experience.   
 Also based on the limitations of the current study, researchers may benefit from 
gathering information on the BPS experiences of IRF patients with other conditions to 
determine whether COPD patients fare worse psychologically, socially, and physically.  
To elicit further understanding of the BPS differences between men and women with 
COPD, researchers may benefit from utilizing a variety of tools to assess BPS factors.  
Also, choosing measures that assess cognitive, physiological, and affective symptoms of 
depression and anxiety may serve to more fully understand the different experiences of 
men and women with COPD.  
Conclusions 
Overall, the current study has yielded several conclusions.  The effect of chronic 
disease is far-reaching and impacts individuals on a BPS level.  Coping with such 
diseases may prove difficult for those living with them.  COPD is one type of severely 
debilitating chronic disease and is growing in prevalence in the United States.  The fact 
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that individuals with COPD often also experience depression, anxiety, and diminished 
HRQOL has been well established by research guided by the BPS paradigm.  The 
identification of spirituality as a protective factor when considering mood, HRQOL, and 
physical independence has also been recognized in the literature.  Few BPS studies on 
patients with COPD in acute IRF settings, however, have been conducted.  The purpose 
of the current study was to further enhance our understanding of the relationship between 
BPS facets of chronic disease and inpatient rehabilitation with specific focus on patients 
with COPD.  Because aspects of the current study were inconclusive, continued 
evaluation of patients in acute IRF programs is essential to enhance our understanding of 
the patient’s BPS experience of the chronic disease process. 
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 Appendix A: Geriatric Depression Scale (GDS) 
 
1. Are you basically satisfied with your life?  yes/no 
2. Have you dropped many of your activities and interests?  yes/no 
3. Do you feel that your life is empty?  yes/no 
4. Do you often get bored?  yes/no 
5. Are you hopeful about the future?  yes/no 
6. Are you bothered by thoughts you can’t get out of your head?  yes/no 
7. Are you in good spirits most of the time?  yes/no 
8. Are you afraid that something bad is going to happen to you?  yes/no 
9. Do you feel happy most of the time?  yes/no 
10. Do you often feel helpless?  yes/no 
11. Do you often get restless and fidgety?  yes/no 
12. Do you prefer to stay at home, rather than going out and doing new things? yes/no 
13. Do you frequently worry about the future?  yes/no 
14. Do you feel you have more problems with memory than most?  yes/no 
15. Do you think it is wonderful to be alive now?  yes/no 
16. Do you often feel downhearted and blue?  yes/no 
17. Do you feel pretty worthless the way you are now?   yes/no 
18. Do you worry a lot about the past?  yes/no 
19. Do you find life very exciting?  yes/no 
20. Is it hard for you to get started on new projects?  yes/no 
21. Do you feel full of energy?  yes/no 
22. Do you feel that your situation is hopeless?   yes/no 
23. Do you think that most people are better off than you are?  yes/no 
24. Do you frequently get upset over little things?  yes/no 
25. Do you frequently feel like crying?  yes/no 
26. Do you have trouble concentrating? yes/no 
27. Do you enjoy getting up in the morning?  yes/no 
28. Do you prefer to avoid social gatherings?  yes/no 
29. Is it easy for you to make decisions?  yes/no 
30. Is your mind as clear as it used to be?  yes/no 
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Appendix B: Informed Consent 
Cardinal Hill Rehabilitation Hospital 
Adult Inpatient Admission Consent Form 
Patient Name:____________________________________ 
Consent to Treatment:  
I understand my admission to Cardinal Hill and my treatment at Cardinal Hill is indicated 
because of my condition.  I consent to receiving care from Cardinal Hill.  I voluntarily 
authorize and consent to the customary examinations, tests, procedures and emergency 
treatment performed on patients in my condition by hospitals/healthcare centers and to 
the medical treatment ordered by my physician(s). 
I consent to be tested for HIV (the virus that causes AIDS) or any other blood-borne 
infectious disease, for diagnosis or other purposes directly related to medical treatment if 
so ordered by my physician(s).  If a health care worker is exposed to my blood or body 
fluids, Cardinal Hill may at its cost test my blood for any infectious disease.  Cardinal 
Hill shall maintain confidentiality to the extent provided by applicable law: a) the fact 
that a blood test is ordered and, b) the results of such tests. 
Treatment with Controlled Substances and Consent to Release KASPER Report: 
Federal and state laws regulate controlled substances (narcotics/drugs) that may be 
abused.  These laws require, under certain circumstances, that a computerized list of 
prescribed narcotics that you may be taking (also known as a KASPER report) be 
obtained from each of your prescribing healthcare providers.  Kentucky law requires that 
you consent to treatment with these drugs before you can receive them.  Some illnesses 
and injuries can result in pain.  Some drugs can make the pain more tolerable.  Some 
other drugs can increase focus and reduce hyperactivity.  Use of these drugs can cause 
nausea, sleepiness, drowsiness, vomiting, constipation, sleeplessness, loss of appetite, 
agitation, aggravation of depression, dry mouth, confusion, slower breathing, and loss of 
coordination making it unsafe to drive or operate machinery.  These drugs can result in 
physical dependence or addiction (meaning that abrupt stopping may lead to withdrawal 
symptoms), psychological dependence or addiction (meaning that abrupt stopping may 
cause you to crave the drug), tolerance (meaning you need more drugs to get the same 
effect) and addiction (meaning you may develop problems based on genetic or other 
factors).  I consent to allow a listing of prescribed narcotics and drugs to be obtained 
from each of my healthcare providers in accordance with state law.  
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Consent for Photographs: 
I consent to allow the staff to photograph me including documentation of my clinical 
condition upon and during my admission, including taking photographs, video or other 
likenesses of me.  
Disclosure of Health Information and Assignment of Benefits: 
I authorize Cardinal Hill to release a summary of my care to any medical institution or 
physician responsible for the care subsequent to my discharge from Cardinal Hill. 
I authorize payment of my insurance benefits to Cardinal Hill and the Physicians named 
on my insurance claim form.  I further authorize release of information required by any 
third-party payer regarding any care made relating to me.  A copy of this form can be 
used in place of the original. I understand that I am financially responsible for charges not 
paid by my insurance company within 30 days after billing. 
For an in consideration of hospital services provided, I or my representative assign and 
direct payment of my hospital bill from any amount due to me on my behalf from any 
person, corporation, insurance carrier, or from any settlement of judgment in any civil 
action. 
Medicare Patients Only: 
I certify that the information I have given in applying for payment under Title XVIII of 
the Social Security Act is correct.  I authorize any holder of medical or other information 
about me to release that information to the Social Security Administration, the Medicare 
Program or their intermediaries or carriers.  I request that payment of authorized benefits 
be made on my behalf. 
Consent to Physician Status as Independent Contractors: 
I understand that physicians (i.e. surgeons, physiatrists, radiologists, pathologists, etc.) 
who may render care or services may not be employees or agents of Cardinal Hill.  I 
understand I will be billed separately for the services of all physicians.  These charges are 
established by the physicians.  
The undersigned agrees that the provisions regarding the release of information and 
assignment of benefits stated in the previous section shall apply to the hospital, and to 
such professionals and suppliers of services, or any of them, and their claims for 
payment.  The undersigned further agrees that the execution of this document does not in 
any way imply that Cardinal Hill neither is responsible nor assumes any liability arising 
for the activities of any such professionals or suppliers of services.  
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I understand that this facility does not employ all healthcare professionals including but 
not limited to physicians, residents, interns or certified registered nurse practitioners with 
whom I may come in contact either directly or indirectly.  I acknowledge that these 
healthcare providers as well as my outside private physician are independent contractors 
who have been granted the privilege of using this facility for the management and 
treatment of patients.  It is recognized that some of these healthcare providers as well as 
my outside private physician are independent contractors who are not agents of Cardinal 
Hill.  Since these independent contractors are not agents of Cardinal Hill it is agreed that 
Cardinal Hill is not liable for their acts under the laws of the Commonwealth of 
Kentucky.  
Waiver of Liability for Loss of Personal Articles:  
I understand that Cardinal Hill maintains a safe for cash and valuables.  I understand that 
Cardinal Hill will not be responsible for the loss of any cash, credit cards, personal items, 
valuables, etc., that are taken to my room.  
Inpatients Only: 
Authorization for Leaving the Hospital Premises:  
It is understood that patients may leave the hospital in accordance with the rules and 
regulations and that any violation thereof may result in discharge.  It is further understood 
that the hospital is not responsible or liable for accidents or illnesses occurring while the 
patient is absent from its campus.  
If a patient is not of legal age (18 years), cross out and initial any item (A) through (C) 
which is not authorized: 
A.________Patient may leave the hospital if accompanied by an authorized staff 
member. 
B.________Patient may leave the hospital if accompanied by an authorized adult member 
of the family.  
C.________Patient may leave the hospital if accompanied by other adults listed below: 
______________________________________________________________________ 
Advance Directive:  (Cornea/Tissue Donor, Durable Power of Attorney, Living Will, 
Health Care Surrogate Declaration) 
______I have given a copy of my Advance Directive to the Admission Clerk at Cardinal 
Hill.  This Advance Directive will govern my course of care in as much as is possible 
under state and federal law. 
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______I have an Advance Directive but do not have a copy with me at this time.  The 
directive cannot govern my course of care at Cardinal Hill until a copy for the medical 
record is provided and reviewed by an attending physician.  However, I understand that it 
is still my right to make decisions regarding my course of treatment. 
______I do not have an Advance Directive but I understand that it is my right to make 
decisions regarding my course of treatment, including the executing Advance Directives.  
I have been given information on how to obtain an Advance Directive. 
______A copy of my Advance Directive is on file from my previous admission.  I verify 
that it is still in effect as written at that time.  I understand that I may be asked to provide 
an additional copy of the directive.  This directive will govern my care, in as much as is 
possible under state and federal law. 
Consent for Future Contact:  
I consent to be placed on the Cardinal Hill mailing list to receive information about 
educational resources, services, programs and fundraising efforts. 
_______________ ______________________________________________________ 
Date:   Signature of Patient or person authorized to sign on behalf of 
patient 
_______________ ______________________________________________________ 
Date:   Witness 
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An Important Message From Medicare About Your Rights 
As a Hospital Inpatient, You Have The Right To: 
• Receive Medicare covered services.  This includes medically necessary hospital 
services and services you may need after you are discharged, if ordered by your 
doctor.  You have a right to know about these services, who will pay for them, 
and where you can get them. 
• Be involved in any decisions about your hospital stay, and know who will pay for 
it. 
• Report any concerns you have about the quality of care you receive to the Quality 
Improvement Organization (QIO) listed here:  Health Care Excel, Incorporated, 
800-288-1499 or TTY:  877-486-2048 
Your Medical Discharge Rights 
Planning For Your Discharge:  During your hospital stay, the hospital staff will be 
working with you to prepare for your safe discharge and arrange for services you may 
need after you leave the hospital.  When you no longer need inpatient hospital care, your 
doctor or the hospital staff will inform you of your planned discharge date. 
If you think you are being discharged too soon: 
• You can talk to the hospital staff, your doctor and your managed care plan (if you 
belong to one) about your concerns. 
• You also have the right to an appeal, this is, a review of your case by a Quality 
Improvement Organization (QIO).  The QIO is an outside reviewer hired by 
Medicare to look at your case to decide whether you are ready to leave the 
hospital.  
o If you want an appeal, you must contact the QIO no later than your 
planned discharge date and before you leave the hospital. 
o If you do this, you will not have to pay for the services you receive during 
the appeal (except for charges like copays and deductibles). 
• If you do not appeal, but decide to stay in the hospital past your planned discharge 
date, you may have to pay for any services you receive after that date. 
• Step by step instructions for calling the QIO and filing an appeal are on page 2.  
To speak with someone at the hospital about this notice, call Paula Epperson at 859-254-
5701 or Teresa Davis at 859-376-7132. 
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Please sign and date here to show you received this notice and understand your 
rights. 
______________________________________________  _______________ 
Signature of Patient or Representative    Date/Time 
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Steps To Appeal Your Discharge 
• Step 1:  You must contact the QIO no later than your planned discharge date and 
before you leave the hospital.  If you do this, you will not have to pay for the 
services you receive during the appeal (except for charges like copays and 
deductibles). 
o Here is the contact information for the QIO: 
Health Care Excel, Incorporated, 800-288-1499 or TTY:  877-486-2048 
o You can file a request for an appeal any day of the week.  Once you speak 
to someone or leave a message, your appeal has begun. 
o Ask the hospital if you need help contacting the QIO. 
o The name of the hospital is: 
Cardinal Hill Rehabilitation Hospital 
Provider ID Number:  183026 
• Step 2:  You will receive a detailed notice from the hospital or your Medicare 
Advantage or other Medicare managed care plan (if you belong to one) that 
explains the reasons they think you are ready to be discharged.  
• Step 3:  The QIO will ask for your opinion.  You or your representative need to 
be available to speak with the QIO, if requested.  You or your representative may 
give the QIO a written statement, but you are not required to do so. 
• Step 4:  The QIO will review your medical records and other important 
information about your case. 
• Step 5:  The QIO will notify you of its decision within 1 day after it receives all 
necessary information. 
o If the QIO finds that you are not ready to be discharged, Medicare will 
continue to cover your hospital services. 
o If the QIO finds you are ready to be discharged, Medicare will continue to 
cover your services until noon of the day after the QIO notifies you of its 
decision. 
If You Miss The Deadline To Appeal, You Have Other Appeal Rights: 
• You can still ask the QIO or your plan (if you belong to one) for a review of your 
case. 
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o If you have Original Medicare:  Call the QIO listed above. 
o If you belong to a Medicare Advantage Plan or other Medicare managed 
care plan:  Call your plan. 
• If you stay in the hospital, the hospital may charge you for any services you 
receive after your planned discharge date. 
For more information, call 1-800-MEDICARE (1-800-633-4227), or TTY: 1-877-
486-2048. 
Additional Information: 
According to the Paperwork Reduction Act of 1995, no persons are required to respond 
to a collection of information unless it displays a valid OMB control number.  The valid 
OMB control number for this information collection is 0938-0692.  The time required to 
complete this information collection is estimated to average 15 minutes per response, 
including the time to review instructions, search existing data resources, gather the data 
needed, and complete and review the information collection.  If you have comments 
concerning the accuracy of the time estimate(s) or suggestions for improving this form, 
please write to: CMS, 7500 Security Boulevard, Attn: PRA Reports Clearance Officer, 
Mail Stop C4-26-05, Baltimore, Maryland  21244-1850. 
Acknowledgement of Receipt of Notice of Privacy Practices 
Patient Name:____________________________________ 
By signing below, I acknowledge that I have received a copy of the Notice of Privacy 
Practices of Cardinal Hill Healthcare System. 
______________________________________________________________   
Signature of Patient or Legal Representative  
______________________________________________________________Print  
Name of Patient or Legal Representative     
______________________________________________________________   
Description of Legal Representative’s Authority 
______________________Date      
CHHS 10-097 032703 
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Cardinal Hill Rehabilitation IRF 
Inpatient Bill of Rights 
These rights can be exercised on the patient’s behalf by a designated representative, 
surrogate or proxy decision maker if the patient lacks decision making capacity, is legally 
incompetent or is a minor. 
1. The patient has the right to considerate and respectful care.  The patient has the 
right to receive care in a safe setting, free from abuse or harassment.  The patient 
has the right to be free from restraints or seclusion imposed as a means of 
coercion, discipline, convenience or retaliation by staff. 
2. The patient has the right to have a family member or physician of his/her 
choosing notified of his/her admission to the hospital.  The patient has the right to 
be informed of visiting policies, including those setting forth any clinically 
necessary or reasonable restriction or limitation the hospital may need to place on 
such rights and the reasons for those restrictions/limitations. 
3. The patients has the right to obtain from the physician and other direct care givers 
complete, current information concerning diagnosis, treatment and prognosis in 
terms the patient can reasonably be expected to understand.  When it is not 
medically advisable to give such information to the patient, the information 
should be made available to the appropriate person on the patient’s behalf.  The 
patient has the right to know by name the physicians, nurses and others 
responsible for coordinating his/her care, as well as when those involved are 
students, residents or other trainees.  The patient has the right to know that a 
physician is not on the premises 24 hours a day / 7 days a week but that a 
physician is available by phone or pager 24 hours a day / 7 days a week. 
4. The patient has the right to receive from his/her physician information necessary 
to give informed consent prior to the start of any procedure and/or treatment.  
Except in emergencies, such information or for informed consent should include 
(but not necessarily be limited to) the specific procedure and/or treatment as well 
as the medically significant alternatives for care or treatment.  The patient has the 
right to know the name of the person responsible for the procedure and/or 
treatment.  The patient has the right to refuse such action.  In case of such refusal, 
the patient is entitled to other appropriate care and services that the hospital 
provides. 
5. The patient has the right to have an advance directive (such as a living will, health 
care proxy or durable power of attorney for health care) concerning treatment or 
designating a surrogate decision maker with the expectation that the hospital will 
129 
 
honor the intent of that directive to the extent permitted by law and hospital 
policy. 
6. The patient has the right to privacy concerning his/her own medical care program.  
Case discussions, consultation, examination, and treatment are confidential and 
should be conducted discreetly.  Those not directly involved in the patient’s care 
must have the permission of the patient to be present. 
7. The patient has the right to expect that all communications and records pertaining 
to his/her care should be treated as confidential by the hospital, except in cases 
such as suspected abuse and public health hazards when reporting is permitted or 
required by law.  The patient has the right to expect that the hospital will 
emphasize the confidentiality of this information when it releases to it any other 
parties entitled to review information in these records. 
8. The patient has the right to review the records pertaining to his/her medical care 
and the right to access this information and to have the information explained or 
interpreted as necessary, except when restricted by law.  Hospital Policy will be 
followed as it applies to release of information. 
9. The patient has the right to participate in the development and implementation of 
his/her plan of care, discharge plan and pain management plan.  The patient has 
the right to except that within its capacity a hospital must make reasonable 
response to his/her request for services.  The hospital must provide evaluation, 
service, and/or referrals indicated by the urgency of the case.  When medically 
appropriate and legally permissible a patient may be transferred to another facility 
only after he/she has received complete information and explanation concerning 
the need for and alternatives to such a transfer.  The institution to which the 
patient is to be transferred must first have accepted the patient for transfer.  
10. The patient has the right to ask and be informed of the existence of business 
relationships among the hospital, educational institutions, other health care 
providers or payors that may influence the patient’s treatment and care. 
11. The patient has the right to be advised if the hospital proposes to engage in or 
perform human experimentation affecting his/her care or treatment.  The patient 
has the right to refuse to participate in such research projects and, if so, is entitled 
to the most effective care that the hospital can otherwise provide. 
12. The patient has the right to expect reasonable continuity of care.  He/she has the 
right to know in advance what appointment times and physicians are available and 
where.  The patient has the right to expect that the hospital will provide a 
mechanism whereby he/she is informed by his/her physician, or a delegate of the 
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physician, of the patient’s continuing health care requirements following 
discharge.  The patient has the right to be informed by physicians and other 
caregivers of available and realistic patient care options when the provided level 
of hospital care is no longer appropriate. 
13. The patient has the right to be informed of hospital policies and practices that 
relate to patient care, treatment and responsibilities.  The patient has the right to 
be informed of available resources for resolving disputes, grievances and conflicts 
such as Care Managers.  The patient has the right to examine and receive an 
explanation of his/her bill regardless of sources of payment.  
 
131 
 
Patient Assessment Instrument Consent 
Medicare requires rehabilitation hospitals to complete a designated evaluate called a 
“Patient Assessment Instrument” (PAI) on all Medicare patients at admission and 
discharge.  This assessment requires the clinical treatment team to assess your functional 
skills in a variety of areas in order to document improvements made during the inpatient 
rehabilitation program.  While the PAI is required only by Medicare, the clinical 
treatment team at Cardinal Hill Rehabilitation Hospital will use the PAI for all patients in 
order to assure consistency. 
Medicare requires that you be informed of 5 specific rights concerning the Patient 
Assessment Instrument.  Your signature indicates that you have been informed of these 
rights, which are as follows: 
1. I understand that the PAI is used to collect data pertaining to my diagnosis, 
medical condition(s) and functional abilities.  This information contained on the 
PAI at admission and discharge, determines the payment that Cardinal Hill 
Rehabilitation Hospital will receive for the care provided to me. 
2. I understand I have the right to expect that the information collected on the PAI 
will remain confidential and secure.  
3. I understand that the data on the PAI will not be released to others except for 
legitimate purposes allowed by the Federal Privacy Act and Federal and State 
Regulations. 
4. I understand that I have the right to refuse to answer PAI data questions.  
5. I understand that I have the right to see, review, and request changes on the PAI. 
I understand the Patient Bill of Rights reviewed with me and I understand that I need to 
contact my Care Manager if I have any questions concerning these rights. 
I understand the Patient Assessment Instrument rights reviewed with me. 
I understand that refusal to answer PAI questions may result in the inability of the 
treatment team to collect the information needed for the PAI, which is required in order 
for Medicare to pay Cardinal Hill for my rehabilitation program. 
I have been informed and understand that, if I have a concern or a grievance, I need to 
discuss it with my Care Manager, respective Program Manager or Risk Management 
Officer of the facility.  If my concern/grievance is not resolved to my satisfaction, I may 
contact any of the entities below: 
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Commission on Accreditation of Rehabilitation Facilities (CARF) 
CARF 
6951 East Southpoint Road 
Tucson, AZ  85756 
(866) 510-2273 
Kentucky Hospital Licensing 
 Eastern Enforcement Branch 
 P. O. Box 12250 
 455 Park Place 
 Lexington, KY  40511 
 Phone:  (859) 246-2301 
 Fax:  (859) 246-2307 
Medicare (Medicare beneficiaries only) Quality Improvement Organization (QIO) 
 Health Care Excel, Inc. 
 800-288-1499 or 
 TTY:  877-486-2048 
I have received this Patient Bill of Rights and information concerning the PAI instrument 
for Medicare Beneficiaries. 
______________________________________________  _______________ 
Patient Signature (or Patient Representative Signature)  Date 
I have been informed and understand my rights as related to the Patient Bill of Rights 
and, if any of my insurance coverage is provided by Medicare, I understand my rights as 
related to the PAI instrument.  I have been informed that I may contact my Care Manager 
if I have any questions concerning these rights. 
______________________________________________  _______________ 
Patient Signature (or Patient Representative Signature)  Date 
______________________________________________  _______________ 
Clinician/Staff Member Reviewing Rights    Date 
 
Please refer to the Administrative Patient Rights Policy on file.  
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